10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: December 31, 2018

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-31990

TEL-INSTRUMENT ELECTRONICS CORP.

(Exact name of registrant as specified in its charter)

New Jersey	22-1441806
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

One Branca Road

East Rutherford, NJ 07073

(Address of principal executive offices)

(201) 933-1600

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒   No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒   No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐ (Do not check if a smaller reporting company)	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐   No ☒

As of February 7, 2019, there were 3,255,887 shares outstanding of the registrant’s common stock.

TEL-INSTRUMENT ELECTRONICS CORP.

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION
		Page
Item 1.	Consolidated Financial Statements.	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	19
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	25
Item 4.	Controls and Procedures.	25
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings.	26
Item 1A.	Risk Factors.	26
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	26
Item 3.	Defaults Upon Senior Securities.	26
Item 4.	Mine Safety Disclosures.	26
Item 5.	Other Information.	26
Item 6.	Exhibits.	27
Signatures		28

PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements.

TEL-INSTRUMENT ELECTRONICS CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

	December 31, 2018			March 31, 2018
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	161,031		$	307,812
Accounts receivable, net		2,271,510			1,095,049
Inventories, net		3,094,276			4,269,934
Restricted cash to support appeal bond		2,003,883			2,000,866
Prepaid expenses and other current assets		240,390			147,746
Total current assets		7,771,090			7,821,407
Equipment and leasehold improvements, net		128,148			180,763
Deferred tax asset, net		63,500			63,500
Other long-term assets		35,109			35,109
Total assets		7,997,847			8,100,779
LIABILITIES & STOCKHOLDERS’ DEFICIT
Current liabilities:
Current portion of long-term debt		-			2,124
Line of credit		820,000			1,000,000
Capital lease obligations – current portion		7,368			6,875
Accounts payable and accrued liabilities		1,796,782			2,580,383
Deferred revenues – current portion		92,204			60,051
Accrued legal damages		5,216,647			5,059,990
Warrant liability		23,000			-
Accrued payroll, vacation pay and payroll taxes		315,575			447,863
Total current liabilities		8,271,576			9,157,286
Capital lease obligations – long-term		1,295			6,885
Deferred revenues – long-term		274,170			337,676
Total liabilities		8,547,041			9,501,847
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, 1,000,000 shares authorized, par value $0.10 per share
Preferred stock, 500,000 shares 8% Cumulative Series A Convertible Preferred issued and outstanding, par value $0.10 per share		3,215,998			3,035,998
Preferred stock, 166,667 shares 8% Cumulative Series B Convertible Preferred issued and outstanding, par value $0.10 per share		1,007,036			-
Common stock, 7,000,000 shares authorized, par value $0.10 per share, 3,255,887 shares issued and outstanding, respectively		325,586			325,586
Paid-in capital in excess of par value, common stock		8,009,843			8,046,975
Accumulated deficit		(13,107,657	)		(12,809,627	)
Total stockholders’ deficit		(549,194	)		(1,401,068	)
Total liabilities and stockholders’ deficit	$	7,997,847		$	8,100,779

See accompanying notes to condensed consolidated financial statements.

3

TEL-INSTRUMENT ELECTRONICS CORP.

 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended						Nine Months Ended
	December 31, 2018			December 31, 2017			December 31, 2018			December 31, 2017
Net sales	$	3,975,736		$	2,625,793			8,012,891		$	7,955,035
Cost of sales		2,006,132			1,689,113			4,562,761			5,377,195
Gross margin		1,969,604			936,680			3,450,130			2,577,840
Operating expenses:
Selling, general and administrative		530,180			548,391			1,652,116			1,881,072
Litigation expenses		59,680			134,765			134,799			560,610
Legal damages		-			-			-			2,100,000
Engineering, research and development		622,082			546,691			1,642,785			1,691,631
Total operating expenses		1,211,942			1,229,847			3,429,700			6,233,313
Income (loss) from operations		757,662			(293,167	)		20,430			(3,655,473	)
Other income (expense):
Interest income		1,010			-			3,017			-
Proceeds from life insurance		-			-			-			92,678
Amortization of deferred financing costs		-			(649	)		-			(3,363	)
Change in fair value of common stock warrants		(23,000	)		5,000			(23,000	)		95,000
Interest expense - judgment		(72,003	)		(30,523	)		(215,226	)		(30,523	)
Interest expense		(24,216	)		(14,097	)		(83,251	)		(38,435	)
Total other (expense) income		(118,209	)		(40,269	)		(318,460	)		115,357
Income (loss) before income taxes		639,453			(333,436	)		(298,030	)		(3,540,116	)
Income tax expense		-			-			-			-
Net income (loss)		639,453			(333,436	)		(298,030	)		(3,540,116	)
Deemed dividend related to beneficial conversion feature         of Series B Convertible Preferred Stock		(420,000	)		-			(420,000	)		-
Preferred stock dividends		(112,807	)		(30,667	)		(232,807	)		(30,667	)
Net income (loss) attributable to common shareholders	$	106,646		$	(364,103	)	$	(950,837	)	$	(3,570,783	)
Basic income (loss) per common share	$	0.03		$	(0.11	)	$	(0.29	)	$	(1.10	)
Diluted income (loss) per common share	$	0.03		$	(0.11	)	$	(0.29	)	$	(1.10	)
Weighted average shares outstanding:
Basic		3,255,887			3,255,887			3,255,887			3,255,887
Diluted		3,409,657			3,255,887			3,255,887			3,255,887

See accompanying notes to condensed consolidated financial statements.

4

TEL-INSTRUMENT ELECTRONICS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended
	December 31, 2018			December 31, 2017
Cash flows from operating activities:
Net loss	$	(298,030	)	$	(3,540,116	)
Adjustments to reconcile net loss to net cash     used in operating activities:
Deferred income taxes		-			-
Depreciation and amortization		52,615			53,221
Provision for inventory obsolescence		55,000			50,000
Amortization of deferred financing costs		-			3,363
Change in fair value of common stock warrant		23,000			(95,000	)
Non-cash stock-based compensation		18,597			23,180
Changes in assets and liabilities:
Increase in accounts receivable		(1,176,461	)		(104,375	)
Decrease (increase) in inventories		1,120,658			(151,145	)
(Increase) decrease in prepaid expenses & other assets		(92,644	)		76,165
Increase in restricted cash for appeal bond		(3,017	)		-
(Decrease) increase in accounts payable and other accrued expenses		(783,601	)		358,808
Decrease in federal and state taxes		-			(4,105	)
Decrease in accrued payroll, vacation pay & withholdings		(132,288	)		(131,206	)
Decrease in deferred revenues		(31,353	)		(68,742	)
Increase in accrued legal damages		156,657			2,130,523
Restricted cash for appeal bond		-			(2,000,000	)
Net cash used in operating activities		(1,090,867	)		(3,399,429	)
Cash flows from investing activities:
Purchases of equipment		-			(89,396	)
Net cash used in investing activities		-			(89,396	)
Cash flows from financing activities:
Proceeds from line of credit		-			800,000
Repayment of line of credit		(180,000	)		-
Proceeds from issuance of preferred stock, net of expenses		987,925			2,960,000
Repayment of long-term debt		(2,124	)		(290,419	)
Proceeds from short-swing profits from an investor, net of expenses		143,382			-
Repayment of capitalized lease obligations		(5,097	)		(4,646	)
Net cash provided by financing activities		944,086			3,464,935
Net decrease in cash and cash equivalents		(146,781	)		(23,890	)
Cash and cash equivalents at beginning of period		307,812			287,873
Cash and cash equivalents at end of period	$	161,031		$	263,983
Supplemental cash flow information:
Taxes paid	$	-		$	5,000
Interest paid	$	41,475		$	50,374

See accompanying notes to condensed consolidated financial statements.

5

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. (the “Company” or “TIC” or “Tel”) as of December 31, 2018, the results of operations for the three and nine months ended December 31, 2018 and December 31, 2017, and statements of cash flows for the nine months ended December 31, 2018 and December 31, 2017.  These results are not necessarily indicative of the results to be expected for the full year.  The financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K.  The March 31, 2018 balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date.  Accordingly, the financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2018, as filed with the United States Securities and Exchange Commission (the “SEC”) on July 16, 2018 (the “Annual Report”).

Note 2 – Liquidity and Going Concern

These consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern.  As reflected in the accompanying financial statements, for the year ended March 31, 2018, the Company incurred a net loss of $4,322,311 and a loss of $298,030 for the nine months ended December 31, 2018. As discussed in Note 15 to the Notes to the Condensed Consolidated Financial Statements, the Company has recorded estimated damages to date of $5,216,647, including interest and additional fees, as a result of the jury verdict associated with the Aeroflex litigation. The Company has filed for an appeal.

The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company’s post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim.  The Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. The Court heard these motions and such motions were denied. The Company has filed for the appeal. The Company has posted a $2,000,000 bond for the appeal. This $2 million bond amount will remain in place during the appeal process (See Note 15). The Company believes it has solid grounds to appeal this verdict. The appeal process is expected to take several years to complete. However, the Company cannot predict the timing or the outcome of the appeal.

The Company believes it has sufficient financing in place to fund its plans for the next twelve months due in part to recent large orders it has received that should return the Company to profitability. The Company’s line of credit agreement expires on May 31, 2019.  On October 5, 2018, the Company entered into a definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock (the “Series B Preferred”) for $1 million. The Company intends to use such proceeds for working capital purposes. We have no other firm commitments from any party to provide additional working capital and there is no assurance that any funding will be available as required, or if available, that its terms will be favorable or acceptable to the Company. The pending judgment raises substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.

The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 3 – Summary of Significant Accounting Policies

During the nine months ended December 31, 2018, there have been no material changes in the Company’s significant accounting policies to those previously disclosed in the Annual Report.

6

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 4 – Accounts Receivable, net

The following table sets forth the components of accounts receivable:

	December 31, 2018			March 31, 2018
Government	$	2,208,470		$	998,522
Commercial		70,540			104,027
Less: Allowance for doubtful accounts		(7,500	)		(7,500	)
	$	2,271,510		$	1,095,049

Note 5 – Restricted Cash to support appeal bond

The Company transferred $2,000,000 to a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Notes 13 and 15).

Note 6 – Inventories, net

Inventories consist of:

	December 31, 2018			March 31, 2018
Purchased parts	$	2,799,562		$	3,571,874
Work-in-process		769,714			1,051,725
Finished goods		-			66,335
Less: Inventory reserve		(475,000	)		(420,000	)
	$	3,094,276		$	4,269,934

Note 7 – Net Income (Loss) per Share

Net income (loss) per share has been computed according to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 260”), “Earnings per Share,” which requires a dual presentation of basic and diluted income (loss) per share (“EPS”). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including preferred stock, warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation costs attributed to future services. 

	Three Months Ended			Three Months Ended
	December 31, 2018			December 31, 2017
Basic net income (loss) per share computation:
Net income (loss)	$	639,453		$	(333,436	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(112,807	)		(30,667	)
Net income (loss) attributable to common shareholders		106,646			(364,103	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net income (loss) per share	$	0.03		$	(0.11	)
Diluted net income (loss) per share computation
Net income (loss)	$	639,453		$	(333,436	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(112,807	)		(30,667	)
Diluted income (loss) attributable to common shareholders	$	106,646			(364,103	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed exercise of       preferred stock, outstanding stock options and warrants		153,770			-
Total adjusted weighted-average shares		3,409,657			3,255,887
Diluted net income (loss) per share	$	0.03		$	(0.11	)

7

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 7 – Net Loss per Share (Continued)

	Nine Months Ended			Nine Months Ended
	December 31, 2018			December 31, 2017
Basic net loss per share computation:
Net loss	$	(298,030	)	$	(3,540,116	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(232,807	)		(30,667	)
Net loss attributable to common shareholders		(950,837	)		(3,570,783	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net income per share	$	(0.29	)	$	(1.10	)
Diluted net loss per share computation
Net loss	$	(298,030	)	$	(3,540,116	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)
Add: Preferred dividends		(232,807	)		(30,667	)
Diluted loss attributable to common shareholders	$	(950,837	)		(3,570,783	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants		-			-
Total adjusted weighted-average shares		3,255,887			3,255,887
Diluted net loss per share	$	(0.29	)	$	(1.10	)

The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share:

	December 31, 2018		December 31, 2017
Convertible preferred stock (see Notes 13 and 14 for amounts to      be paid for conversion which the Company would receive)		1,599,778		1,000,000
Stock options		42,500		75,000
Warrants		50,000		50,000
		1,692,278		1,125,000

Note 8 – Long-Term Debt

Term Loans with Bank of America

In July 2015, the Company entered into a term loan in the amount of $18,000 with Bank of America. The term loan was for three years, and matured in July 2018. Monthly payments were $536 including interest at 4.5%. The term loan was collateralized by substantially all of the assets of the Company. At December 31, 2018 and March 31, 2018, the outstanding balances were $-0- and $2,124, respectively. This loan was paid in full in July 2018.

8

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 9 – Line of Credit

On March 21, 2016, the Company entered into a line of credit agreement with Bank of America, which expired March 31, 2017. In March 2017, the Company extended until March 31, 2018.  The line provided a revolving credit facility with borrowing capacity of up to $1,000,000. There were no covenants or borrowing base calculations associated with this line of credit. On August 29, 2018, the Company entered a Loan Modification Agreement (the “Agreement”) with the bank. The Company had been working with the bank and had paid $100,000 to the bank to lower the outstanding balance to $900,000 at the signing of the Agreement. The Agreement has the following provisions:

1) The Company to make an additional principal payment of $50,000 by October 1, 2018. (The Company made this payment.)

2) Borrowing base calculation tied to accounts receivable and inventories.

3) The Agreement expires May 31, 2019.

4) Interest on any outstanding balances is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points. The Company’s interest rate was 5.915% at September 30, 2018.

5) The line is collateralized by substantially all of the assets of the Company. 

6) The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019.

7) Beginning with the fiscal year ended March 31, 2019, the Company must maintain a debt service coverage ratio.

During the nine months ended December 31, 2018, the Company repaid $180,000 against this line of credit. As of December 31, 2018 and March 31, 2018, the outstanding balances were $820,000 and $1,000,000, respectively.  As of December 31, 2018 the remaining availability under this line is $-0-.

Note 10 – Segment Information

In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial. There are no inter-segment revenues.

The Company is organized primarily on the basis of its avionics products.  The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors.  The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops. The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments.

Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis.  Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level. The table below presents information about reportable segments within the avionics business for the three and nine month periods ending December 31, 2018 and 2017:

Three Months Ended  December 31, 2018	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	3,484,380	$	491,356	$	3,975,736	$	-		$	3,975,736
Cost of sales		1,735,573		270,559		2,006,132		-			2,006,132
Gross margin		1,748,807		220,797		1,969,604		-			1,969,604
Engineering, research, and development						622,082		-			622,082
Selling, general and administrative						228,107		302,073			530,180
Litigation costs								59,680			59,680
Change in fair value of common stock warrants								23,000			23,000
Interest income						-		(1,010	)		(1,010	)
Interest expense - judgment								72,003			72,003
Interest expense						-		24,216			24,216
Total expenses						850,189		479,962			1,330,151
Income (loss) before income taxes					$	1,119,415	$	(479,962	)	$	639,453

9

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 10 – Segment Information (continued)

Three Months Ended  December 31, 2017	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	1,825,744	$	800,049	$	2,625,793	$	-		$	2,625,793
Cost of sales		1,013,481		675,632		1,689,113		-			1,689,113
Gross margin		812,263		124,417		936,680		-			936,680
Engineering, research, and development						546,691		-			546,691
Selling, general and administrative						225,610		322,781			548,391
Litigation costs								134,765			134,765
Legal damages								30,523			30,523
Amortization of deferred financing costs						-		649			649
Change in fair value of common stock warrants						-		(5,000	)		(5,000	)
Proceeds from life insurance								-			-
Interest expense						-		14,097			14,097
Total expenses						772,301		497,815			1,270,116
Income (loss) before income taxes					$	164,379	$	(497,815	)	$	(333,436	)

Nine Months Ended  December 31, 2018	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	5,861,061	$	2,151,830	$	8,012,891	$	-		$	8,012,891
Cost of sales		3,211,417		1,351,344		4,562,761		-			4,562,761
Gross margin		2,649,644		800,486		3,450,130		-			3,450,130
Engineering, research, and development						1,642,785		-			1,642,785
Selling, general and administrative						639,414		1,012,702			1,652,116
Litigation costs								134,799			134,799
Change in fair value of common stock warrants						-		23,000			23,000
Interest income								(3,017	)		(3,017	)
Interest expense - judgment								215,226			215,226
Interest expense						-		83,251			83,251
Total expenses						2,282,199		1,465,961			3,748,160
Income (loss) before income taxes					$	1,167,931	$	(1,465,961	)	$	(298,030	)

Nine Months Ended  December 31, 2017	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	5,826,763	$	2,128,272	$	7,955,035	$	-		$	7,955,035
Cost of sales		3,489,223		1,887,972		5,377,195		-			5,377,195
Gross margin		2,337,540		240,300		2,577,840		-			2,577,840
Engineering, research, and development						1,691,631		-			1,691,631
Selling, general and administrative						861,795		1,019,277			1,881,072
Litigation costs								560,610			560,610
Legal damages								2,130,523			2,130,523
Amortization of deferred financing costs						-		3,363			3,363
Change in fair value of common stock warrants						-		(95,000	)		(95,000	)
Proceeds from life insurance								(92,678	)		(92,678	)
Interest expense, net						-		38,435			38,435
Total expenses						2,553,426		3,564,530			6,117,956
Income (loss) before income taxes					$	24,414	$	(3,564,530	)	$	(3,540,116	)

10

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 11 – Income Taxes

FASB ASC 740-10, “Accounting for Uncertainty in Income Taxes” (“ASC 740-10”) prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions.  The Company does not have any unrecognized tax benefits.

The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset.  Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse.  The Company has approximately $3.5 million in deferred tax assets, and we have provided a valuation allowance that offsets the majority of the asset. The inability to obtain new profitable contracts or the failure of the Company’s engineering development efforts could reduce estimates of future profitability, which could affect the Company’s ability to realize the deferred tax assets. Due to the adverse judgment and the resulting losses the past few years, management has established a valuation allowance against this deferred tax asset. This valuation allowance could be reversed when the Company returns to profitability, and can demonstrate that it will be able to utilize the deferred tax asset.

Note 12 – Fair Value Measurements

FASB ASC 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”) defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and expands disclosures about fair value measurements.

As defined in ASC 820-10, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price).  The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique.  These inputs can be readily observable, market corroborated, or generally unobservable.  The Company classifies fair value balances based on the observation of those inputs. ASC 820-10 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy defined by ASC 820-10 are as follows:

-  Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.  Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

-  Level 2 – Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date.  Level 2 includes those financial instruments that are valued using models or other valuation methodologies.  These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.  Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.  Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

-  Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources.  These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

11

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 12 – Fair Value Measurements (continued)

 The valuation techniques that may be used to measure fair value are as follows:

● Market approach — Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

● Income approach — Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method.

● Cost approach — Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost). 

The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility reflect currently available terms and conditions for similar debt.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of December 31, 2018 and March 31, 2018.  As required by ASC 820-10, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.

December 31, 2018	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		23,000		23,000
Total Liabilities	$	-	$	-	$	23,000	$	23,000

March 31, 2018	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		-		-
Total Liabilities	$	-	$	-	$	-	$	-

The Company adopted the guidance of ASC 815 “Derivative and Hedging”, which requires that we mark the value of our warrant liability to market and recognize the change in valuation in our statement of operations each reporting period. Determining the warrant liability to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  

The following table provides a summary of the changes in fair value of our Level 3 financial liabilities from March 31, 2018 through December 31, 2018, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to the liability held at December 31, 2018:

Level 3 Reconciliation	Balance at beginning of period		(Gains) and losses for the period (realized and unrealized)		Purchases, issuances, sales and settlements, net		Transfers in or out of Level 3		Balance at the end of period
Warrant liability	$	-	$	23,000	$	-	$	-	$	23,000
Total Liabilities	$	-	$	23,000	$	-	$	-	$	23,000

The Company has remaining warrants with an outside investor to purchase 50,000 shares of the Company’s common stock at an exercise price of $3.35 per share or exercising the “put option” to the Company.  The warrant liability of the 50,000 warrants was $23,000 at December 31, 2018 as compared to $-0- at March 31, 2018.

12

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 13 – Series A 8% Convertible Preferred Stock

On November 14, 2017, the Company entered into definitive subscription agreements with an accredited investor, pursuant to which the investor purchased an aggregate of 500,000 shares of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred”) for an aggregate of $3 million. The Company used $2,000,000 of the proceeds to be placed in a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Notes 5 and 15) and the remaining amount was used for working capital purposes, and for payment of fees and expenses associated with this transaction. The Closing occurred following the satisfaction of customary closing conditions. The securities issued pursuant to the Subscription Agreements were not registered under the Securities Act of 1933, as amended (the “Securities Act”), but qualified for exemption under Section 4(a)(2) of the Securities Act. The securities were exempt from registration under Section 4(a)(2) of the Securities Act because the issuance of such securities by the Company did not involve a “public offering,” as defined in Section 4(a)(2) of the Securities Act, due to the insubstantial number of persons involved in the transaction, size of the offering, manner of the offering and number of securities offered. The Company did not undertake an offering in which it sold a high number of securities to a high number of investors. In addition, these shareholders had the necessary investment intent as required by Section 4(a)(2) of the Securities Act since they agreed to, and received, share certificates bearing a legend stating that such securities are restricted pursuant to Rule 144 of the Securities Act. This restriction ensures that these securities would not be immediately redistributed into the market and therefore not be part of a “public offering.” Based on an analysis of the above factors, the Company has met the requirements to qualify for exemption under Section 4(a)(2) of the Securities Act.

The shares of Series A Preferred have a stated value of $6.00 per share (the “Series A Stated Value”) and are convertible into Common Stock at a price of $3.00 per share. The holders of shares of the Series A Preferred shall be entitled to receive dividends out of any assets legally available, to the extent permitted by New Jersey law, at an annual rate equal to 8% of the Series A Stated Value of such shares of Series A Preferred, calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series A Preferred, payable quarterly in cash. Any unpaid dividends shall accrue at the same rate. To the extent not paid on the last day of March, June, September and December of each calendar year, all dividends on any share of Series A Preferred shall accumulate whether or not declared by the Board and shall remain accumulated dividends until paid. As of December 31, 2018, the Company has accrued $330,667 for dividends.

The Holders will vote together with the holders of the Company’s Common Stock on an as-converted basis on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). Effective beginning on the third anniversary of the Original Issue Date, and upon 30 days’ written notice to the Holders of Series A Preferred, the Company may, in its sole discretion, redeem the Series A Preferred at the aggregate Series A Stated Value plus any accrued and accumulated but unpaid dividends.

The Company has also evaluated its convertible preferred stock in accordance with the provisions of ASC 815, Derivatives and Hedging, including consideration of embedded derivatives requiring bifurcation. The issuance of the convertible preferred stock could generate a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Series A Convertible Preferred Stock, and the associated dividends, did not generate a BCF upon issuance as the fair value of the Company's common stock was greater than the conversion price. During the quarter December 31, 2018 the Company measured a BCF based on the fair value of our stock price on the date dividends were declared. The BCF amounted to $16,200 on the associated dividend.

Note 14 – Series B 8% Convertible Preferred Stock

On October 5, 2018, the Company entered into definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock (the “Series B Preferred”) for an aggregate of $1 million. The Company used such proceeds for working capital to finance its operations based on the current and expected increase in business, and for payment of fees and expenses associated with this transaction. The Closing occurred following the satisfaction of customary closing conditions. The securities issued pursuant to this subscription agreement were not registered under the Securities Act of 1933, as amended (the “Securities Act”), but qualified for exemption under Section 4(a)(2) of the Securities Act. The securities were exempt from registration under Section 4(a)(2) of the Securities Act because the issuance of such securities by the Company did not involve a “public offering,” as defined in Section 4(a)(2) of the Securities Act, due to the insubstantial number of persons involved in the transaction, size of the offering, manner of the offering and number of securities offered. The Company did not undertake an offering in which it sold a high number of securities to a high number of investors. In addition, this individual had the necessary investment intent as required by Section 4(a)(2) of the Securities Act since he agreed to, receive share certificates bearing a legend stating that such securities are restricted pursuant to Rule 144 of the Securities Act. This restriction ensures that these securities would not be immediately redistributed into the market and therefore not be part of a “public offering.” Based on an analysis of the above factors, the Company has met the requirements to qualify for exemption under Section 4(a)(2) of the Securities Act.

13

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 14 – Series B 8% Convertible Preferred Stock (continued)

The shares of Series B Preferred have a stated value of $6.00 per share (the “Series B Stated Value”) and are convertible into Common Stock at a price of $2.00 per share. The holder of shares of the Series B Preferred shall be entitled to receive dividends out of any assets legally available, to the extent permitted by New Jersey law, at an annual rate equal to 8% of the Series B Stated Value of such shares of Series B Preferred, calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series B Preferred, payable quarterly in cash. Any unpaid dividends shall accrue at the same rate. To the extent not paid on the last day of March, June, September and December of each calendar year, all dividends on any share of Series B Preferred shall accumulate whether or not declared by the Board and shall remain accumulated dividends until paid. As of December 31, 2018, the Company accrued $19,111 for dividends.

The Holders will vote together with the holders of the Company’s Common Stock on an as-converted basis on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). Effective beginning on the third anniversary of the Original Issue Date, and upon 30 days’ written notice to the Holders of Series B Preferred, the Company may, in its sole discretion, redeem the Series B Preferred at the aggregate Series B Stated Value plus any accrued and accumulated but unpaid dividends.

The Company has also evaluated its convertible preferred stock in accordance with the provisions of ASC 815, Derivatives and Hedging, including consideration of embedded derivatives requiring bifurcation. The issuance of the convertible preferred stock could generate a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Company recognized the BCF by allocating the intrinsic value of the conversion option, which is the number of shares of common stock available upon conversion multiplied by the difference between the effective conversion price per share and the fair value of common stock per share on the commitment date, to additional paid-in capital, resulting in a discount on the convertible preferred stock. As the convertible preferred stock may be converted immediately, the Company recognized a BCF of $420,000 as a deemed dividend in the condensed statements of operations for the three and nine months ended December 31, 2018. The deemed dividend had no impact on the Company’s stockholders’ deficit. The associated dividend for the Series B preferred stock generated a BCF in the amount of $17,496 for the period ended December 31, 2018.

Note 15 – Litigation

Contingencies are recorded in the consolidated financial statements when it is probable that a liability will be incurred and the amount of the loss is reasonably estimable, or otherwise disclosed, in accordance with Accounting Standards Codification 450, Contingencies (ASC 450). Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In the event the Company determines that a loss is not probable, but is reasonably possible, and it becomes possible to develop what the Company believes to be a reasonable range of possible loss, then the Company will include disclosures related to such matter as appropriate and in compliance with ASC 450. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company will, when applicable, adjust the accrual in the period the determination is made, disclose an estimate of the additional loss or range of loss or if the amount of such adjustment cannot be reasonably estimated, disclose that an estimate cannot be made.

On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the “Award”). Aeroflex’s petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with Aeroflex’s business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex’s contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award.  In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”).

In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed on Aeroflex’s proprietary technology in winning the Award, and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.

14

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 15 – Litigation (continued)

In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings.

On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex’s lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire. Aeroflex’s claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2011. The motion for summary judgment was denied.

The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a nine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company.

Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex’s tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.  Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.

During July 2017, the Court heard the Company’s motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million.

Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In October 2017, the Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages, which brings the total Tel damages awarded in this case to approximately $4.9 million.

The Company filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. A hearing on this motion was held. The Judge rejected all of our arguments and declined to order a new trial. We filed the appeal document the week of May 28. The Company has posted a $2,000,000 bond. This $2 million bond amount will remain in place during the appeal process (See Note 5).

On July 5, 2018, Plaintiff Aeroflex Wichita, Inc. filed a Notice of Cross-Appeal which is contingent in nature in that it seeks a review of all adverse rulings relating to its Motion for Relief and Sanctions; Defendants’ Motions for Summary Judgment; determining that certain matters were not trade secrets; Defendants’ joint and several liability; preemption under the Kansas Uniform Trade Secrets Act; motions in limine; motions for judgment as a matter of law; jury instructions; admission of evidence over its objections; and all other rulings adverse to it only if the court reverses the jury verdict and judgment. Aeroflex Wichita also reserved the right to ask the reviewing court to order a new trial either on damages alone or on liability for all claims. This reservation of rights is also contingent upon a finding of the appellate court which would reverse the jury verdict and judgment. Aeroflex Wichita filed its Docketing Statement on July 5, 2018 as well .

On July 11, 2018, the Court of Appeals entered an Order of Referral to Mediation and Order to Stay. The Company’s case was selected to participate in the Kansas Court of Appeals Appellate Mediation pilot program. Participation in the program is voluntary, either party may opt out of participation. The order staying the case was lifted because Aeroflex Wichita, Inc. opted out, and as a result the appeal will proceed under normal procedures.

The Company is continuing with its appeal against this adverse decision. The appeal brief is due to be filed in February 2019. We believe that the trial judge erred in his legal rulings on standing and other issues during the trial and that we have strong grounds for appeal. Our attorneys estimate that it will take several years for this appeal to work its way through the Kansas court system, but that ongoing future legal expenses will be nominal. We believe that we will have approximately two to three years to generate sufficient cash or secure additional financing to support the repayment of the remaining $2.9 million plus accrued interest not covered by the $2 million appeal bond, if we do not prevail with the appeal.

15

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 15 – Litigation (continued)

Other than the matters described above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

Note 16 – New Accounting Pronouncements

Recently Adopted Authoritative Pronouncements

Revenue Recognition

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers: Topic 606 which supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of Topic 606 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The ASU defines a five-step process to achieve the core principal and, in doing so, it is possible more judgement and estimates may be required within the revenue recognition process than are currently in use. The ASU was effective for the Company in the first quarter of 2019 using either of two methods: (1) retrospective application to each prior reporting period presented with the option to elect certain practical expedients or (2) retrospective application with the cumulative effect of initially applying the ASU recognized at the date of the initial application and providing certain disclosures. We adopted Topic 606 pursuant to the method (2) and we determined that any cumulative effect for the initial application did not require an adjustment to retained earnings at April 1, 2018.

The Company generates revenue from designing, manufacturing and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment. 

Under Financial Accounting Standards Board (“FASB”) Topic 606, Revenue from Contacts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

Nature of goods and services

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each.

Test Units/Sets

The Company develops, and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for radios installed in aircraft. The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract. Revenue on products are presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement, and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to the customer.

16

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 16 – New Accounting Pronouncements (continued)

Recently Adopted Authoritative Pronouncements (continued)

Revenue Recognition (continued)

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines     stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component as of December 31, 2018.

Replacement Parts

The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test units, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled.

Extended Warranties

The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms generally ranging from 5 to 7 years. Amounts received for warranties are recorded as deferred revenue and recognized as revenue ratably over the respective term of the agreements. As of December 31, 2018, approximately $366,374 is expected to be recognized from remaining performance obligations for extended warranties.  For the nine months ended December 31, 2018, the Company recognized revenue of $33,255 from amounts that were included in Deferred Revenue.

Repair and Calibration Services

The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped, as it is at this time that the work is completed.

The majority of the Company’s revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, and other commercial customers. The contracts with the U.S. government typically are subject to the Federal Acquisition Regulation (“FAR”) which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts.

Payment terms and conditions vary by contract, although terms generally include a requirement of payment within a range from 30 to 60 days, or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts generally do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. Shipping and handling costs charged to customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales. 

17

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 16 – New Accounting Pronouncements (continued)

Recently Adopted Authoritative Pronouncements (continued)

Revenue Recognition (continued)

Disaggregation of revenue

In the following tables, revenue is disaggregated by revenue category.

	For the Three Months Ended December 31, 2018
	Commercial		Government
Sales Distribution
Test Units	$	46,631	$	3,484,380
Repairs and Calibration		366,563		-
Replacement Parts		64,527		-
Extended Warranty		13,635		-
	$	491,356	$	3,484,380

	For the Nine Months Ended December 31, 2018
	Commercial		Government
Sales Distribution
Test Units	$	642,855	$	5,861,061
Repairs and Calibration		1,285,839		-
Replacement Parts		189,881		-
Extended Warranty		33,255		-
	$	2,151,830	$	5,861,061

In the following table, revenue is disaggregated by geography.

	For the Three Months Ended December 31, 2018		For the Nine Months Ended December 31, 2018
Geography
United States	$	3,088,693	$	6,363,404
International		887,043		1,649,487
Total	$	3,975,736	$	8,012,891

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which requires lessees to put most leases on their balance sheets by recognizing a lessee’s rights and obligations, while expenses will continue to be recognized in a similar manner to today’s legacy lease accounting guidance. This ASU could also significantly affect the financial ratios used for external reporting and other purposes, such as debt covenant compliance. This ASU will be effective for the Company on April 1, 2019, with early adoption permitted. The Company is currently in the process of assessing the impact of this ASU on our consolidated financial statements.

No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s consolidated financial statements.

Note 17 – Reclassifications

Certain prior year and period amounts have been reclassified to conform to the current period presentation.

18

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward Looking Statements

This Quarterly Report on Form 10-Q and other reports filed by the Company from time to time with the SEC (collectively the “Filings”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management.  Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof.  When used in the Filings, the words “may”, “will”, “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan”, or the negative of these terms and similar expressions as they relate to the Company or the Company’s management are intended to identify forward-looking statements.  Such statements reflect the current view of the Company with respect to future events and we caution you that these statements are not guarantees of future performance or events and are subject to risks, assumptions, and other factors.  Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements.  Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”).  These accounting principles require us to make certain estimates, judgments and assumptions.  We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made.  These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented.  Our financial statements would be affected to the extent there are material differences between these estimates and actual results.  In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application.  There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result.  The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

Overview

Sales for the quarter ended December 31, 2018 increased 79% to almost $4 million as compared to $2.2 million from the previous quarter ended September 30, 2018. This turnaround is the result of the increased shipment of our Mode 5 test sets, including our T-47M/5, which has recently received AIMS (Air Traffic Control Radar Beacon System, Identification Friend or Foe, Mark XII/Mark XIIA, Systems) approval. As previously reported, the Company has received a $4.3 million order for Mode 5 test sets from the U.S. military. In August 2018, we also reported that the German government had notified our U.K. distributor of its intent to award a multi-year, multi-million dollar contract. In February 2019, the Company received an initial purchase order totaling $520,000 from its European Distributor, Muirhead Avionics (“Muirhead”) for Mode 5 test sets from the contract awarded by the German military. This is a seven-year procurement contract with anticipated orders for the 2019 calendar year of approximately $3.5 million in total.  Excluding the German order, bookings for the recently completed third quarter ended December 31, 2018 totaled approximately $9.7 million and backlog has increased to $7 million from $2 million at September 30, 2018.

The Company has received from Lockheed Martin Mode 5 test set orders for approximately $2.4 million. These units for Lockheed Martin will be used for the Joint Strike Fighter (“JSF”) program, and we believe this program will generate significant CRAFT orders as this program ramps up limited rate production. The Company has already received orders from Lockheed Martin for the AN/USM-708 units, for the JSF Program, totaling approximately $5 million. Sikorsky has also indicated that it will be ordering CRAFT test sets for its new helicopters. The Company also receives orders from other customers for this product.

The Company is also in discussions with other major international customers that have evaluated our Mode 5 test sets and we are excited about the opportunities overseas, as evidenced by the above-mentioned pending order from Germany, but no guarantees can be made about these opportunities. We received and shipped our T-47M/5 Mode 5 test sets to Japan, and have subsequently received an additional order from Japan for approximately $616,000 to be delivered over the next few years. Many other countries have expressed significant interest in our Mode 5 test sets, including Australia, Canada, United Kingdom and South Korea. The Company has built a very solid position in the Mode 5 Identification Friend or Foe (“IFF”) flight line test equipment market, and our products are very competitive in the overseas markets. We believe that we are well-positioned as our CRAFT and TS-4530A flight-line test sets have been endorsed by the U.S. military and we have already delivered test sets into 18 international markets. The new T-47/M5 Mode 5 IFF test set will be a cost-effective upgrade option for our large installed base of Mode 4 test sets and we have seen substantial interest and orders for this test set from a number of countries.  All allied countries have a drop-dead date of January 1, 2020 for Mode 5 capability so we expect this international business will begin to accelerate this year and remain for at least the next three years, based on our current projections. Our expectation is that we will continue to significantly improve both our revenues and gross margins starting in the fourth quarter of 2018 calendar year, but because the timing of these new orders is largely out of our hands, we expect to see continued volatility in our quarterly revenues. Nonetheless, we are encouraged by the increasing activity we are seeing for both our commercial and military products.

19

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).

Overview (continued)

The commercial avionics industry is undergoing a great deal of change and we believe our new lightweight, hand-held products that we are planning to introduce in the near term will generate increased market share at very attractive gross margin levels. The technology for the hand-held product will provide a platform for future products. We are also working closely with our other military customers on new potential market opportunities that will be needed to maintain our sales and profitability growth.

This new technology could provide us with the opportunity to expand out of our relatively narrow avionics test market niche and enter the much larger secure communications radio test market. We are actively working to line up partners to enter this growth market and we believe that our new hardware platform provides unmatched capabilities in a market leading form factor. In March 2018, the Company announced the introduction of its new handheld avionics flight-line Test Set, the “SDR-OMNI”. The world’s first “All-in-One” Avionics Test Set utilizes true software-designed radio technology that enables it to test all common avionics functions in one 4.5 pound test set.

The SDR/OMNI has very wide frequency to accommodate new commercial and military waveforms in an industry leading 4-pound package. This is half the weight of competitive test sets. It utilizes the latest touch screen technology and has the capability to replace all TIC commercial test sets and military flight-line test sets with one handheld product. The initial product will be a commercial avionics air traffic control test set which adds ADS-B UAT test capability for the large general aviation test market that is subject to the January 1, 2020 requirement for ADS-B out capability. This will compete with the Aeroflex IFR 6000 test set and will replace the TIC TR-220 product. This release is targeted at the civil aviation market that is subject to the January 1, 2020 requirement for ADS-B out capability. The initial version of this product should be available towards the end of current fiscal year. The next software release will incorporate Nav/Comm test functions which can be purchased as APP’s (applications) by our customers. We continue to evaluate other attractive potential market opportunities.

The much larger growth potential is in the secure military and homeland security radio test market which is many times the size of our existing avionics test market. The biggest medium term opportunity is for the Marine 3515 secure communication replacement program which is expected to occur in the next two years. This could represent a $40 million opportunity for the Company. We are currently in discussions with various companies about collaborating in these markets.

The Aeroflex litigation (see Note 15 to the Condensed Consolidated Financial Statements) did not result in a favorable outcome for the Company, despite our belief that we committed no wrong doing. The Judge did not change the result or vacate the damage award based on our latest motions, and, as such, we appealed this decision, and filed the appeal document (the “Appeal”) the week of May 28, 2018. The Company has established a $2 million cash bond and has filed an appeal on the $4.9 million in damages awarded by the court. The appeal brief is due to be filed in February 2019. We believe that the trial judge erred in his legal rulings on standing and other issues during the trial and that we have strong grounds for appeal. Our attorneys estimate that it will take several years for this appeal to work its way through the Kansas court system, but that ongoing future legal expenses will be nominal. We believe that we will have approximately two to three years to generate sufficient cash or secure additional financing to support the repayment of the remaining $2.9 million plus accrued interest not covered by the $2 million appeal bond, if we do not prevail with the appeal.

In October 2018, the Company entered into a subscription agreement pursuant to which an investor purchased 166,667 shares of the Company’s Series B Preferred Stock for $1 million. These funds will be used for working capital purposes to support the orders received and expected in the near term.

On August 8, 2018, the Company received a letter from the staff of the NYSE American (the “Exchange”) stating that based on the Company’s financial statements at March 31, 2018, the Company is not in compliance with Section 1003(a)(ii) of the NYSE American Company Guide, which requires that a company’s stockholders’ equity be $4.0 million or more if it has reported net losses in three of its last four fiscal years (the “Stockholders’ Equity Requirement”).

As of March 31, 2018, the Company had a stockholders’ deficit of approximately $1.4 million, and had net losses in three of its last four fiscal years, thus bringing the Company below the Stockholders’ Equity Requirement.  The decline in equity primarily resulted from the accrual of approximately $5 million in damages arising from the Aeroflex litigation as well as over $2 million in litigation costs over the years. The Company also had to record a valuation allowance of approximately $3.5 million against the Company’s deferred tax asset.

The Company prepared a plan (the “Plan”) that was submitted to the Exchange describing the actions the Company is taking to regain compliance with the Stockholders’ Equity Requirement. On December 20, 2018, the Company was advised that NYSE had determined to commence proceedings to delist the stock, despite the fact that we believe that we can achieve compliance by the end of 2019 as a result of the recent turnaround in the business. However, delisting proceedings have been initiated because we would not have been able to regain compliance prior to the deadline of January 29, 2019. The Company’s receipt of such notification from the Exchange does not affect the Company’s business, operations or reporting requirements with the U.S. Securities and Exchange Commission. 

20

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).

Overview (continued)

The Company requested a review of the staff determination to delist the common stock to the committee of the Board of Directors of the Exchange as the Company believes that it will reestablish compliance during the 2019 calendar year based on its greatly improved financial prospects, which have been previously disclosed. The Company will also argue that the positive historical operating performance of the Company has been masked by the adverse results of the Aeroflex litigation. Absent this litigation, which is now in the appeal stage, the Company would have been solidly profitable in three of the last four years. The hearing at the NYSE is currently scheduled for February 11, 2019.

As discussed in recent press releases, the Company anticipates a return to solid profitability starting in the current fiscal quarter ending December 31, 2018. The Company has received new bookings and pending contracts totaling about $10 million in the current fiscal quarter, with additional volume orders expected going forward as the international market finally begins to ramp-up to comply with the January 1, 2020 deadline for Mode 5 compliance. We have several other multi-million solicitations in process from key domestic and international markets, which are expected in the first quarter of next year, and we are optimistic on our prospects as most of these customers are specifying our products. While Tel is confident that it will reestablish compliance with the Stockholders’ Equity Requirement in calendar year 2019, there is no assurance that we will be successful or that the NYSE will not delist the Company after the hearing.

The Company’s common stock will continue to trade on the Exchange until a hearing is held and before the Listing Qualification Panel issues its decision. In the event an additional extension is not granted, the Company’s stock will continue to trade on the OTC and Company management will review alternative listing options.

At December 31, 2018, the Company’s backlog of orders was approximately $7.1 million as compared to $1.4 million at September 30, 2018 and $2.7 million at December 31, 2017. The backlog at December 31, 2018 does not include the pending order from Germany. Historically, the Company obtains orders which are required to be filled in less than 12 months, and therefore, these anticipated orders are not reflected in the backlog. With the pending Mode 5 deadline at January 1, 2020, the Company expects the backlog and sales to be increase over the next year.

Results of Operations

Sales

For the three months ended December 31, 2018, total net sales increased $1,349,943 (51.4%) to $3,975,736 as compared to $2,625,793 for the three months ended December 31, 2017. Avionics government sales increased $1,658,636 (90.8%) to $3,484,380 for the three months ended December 31, 2018, as compared to $1,825,744 for the three months ended December 31, 2017. The increase in sales is mostly attributed to the increase in shipment of our Mode 5 test sets, including our new T-47/M5, TS4530A and our AN/USM-708 CRAFT product as well as increases in some of our legacy military products. Commercial sales decreased $308,693 (38.6%) to $491,356 for the three months ended December 31, 2018 as compared to $800,049 for the three months ended December 31, 2017. This decrease is attributed to the decreased sales from our repair business and lower sales of the TR-220, mostly as a result of the timing of orders that were received late in the quarter and we were not able to get the parts in time to ship as well as available resources.

For the nine months ended December 31, 2018, total net sales increased $57,856 (0.7%) to $8,012,891, as compared to $7,955,035 for the nine months ended December 31, 2017. Avionics government sales increased $34,298 (0.6%) to $5,861,061 for the nine months ended December 31, 2018, as compared to $5,826,763 for the nine months ended December 31, 2017. The increase in sales is mostly attributed to the increase in shipment of our new T-47/M5 and the T-47NH offset mostly by decreases in the TS4530A and our CRAFT products as well as our Precision DME products. Commercial sales increased $23,558 (1.1%) to $2,151,830 for the nine months ended December 31, 2018 as compared to $2,128,272 for the nine months ended December 31, 2017. This modest increase is attributed to the increased sales from our repair business offset mostly by lower sales of the TR-220, mostly as a result of the timing of orders that were received late in the quarter and we were not able to get the parts in time to ship as well as available resources.

As discussed above in the overview section, sales are expected to continue to increase as a result of the $4.3 million order for additional Mode 5 test sets from the U.S. military, sales of our CRAFT for the JSF program, as well as other large expected orders for our Mode 5 test sets both domestically and internationally.

21

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).

Results of Operations (continued)

Gross Margin

For the three months ended December 31, 2018, total gross margin increased $1,032,924 (110.3%) to $1,969,604 as compared to $936,680 for the three months ended December 31, 2017 primarily as a result of the increase in volume as well as the reduction in manufacturing overhead and an increase in manufacturing efficiencies. The gross margin percentage for the three months ended December 31, 2018 was 49.5% as compared to 35.7% for the three months ended December 31, 2017. The higher gross margin percentage is attributable to an improved product mix as well as the reduction in manufacturing overhead as well as manufacturing efficiencies.

For the nine months ended December 31, 2018, total gross margin increased $872,290 (33.8%) to $3,450,130 as compared to $2,577,840 for the nine months ended December 31, 2017 primarily as a result of the reduction in manufacturing overhead and improvement in manufacturing efficiencies as well as higher prices. The gross margin percentage for the nine months ended December 31, 2018 was 43.1% as compared to 32.4% for the three months ended December 31, 2017. The higher gross margin percentage is attributable to the reduction in manufacturing overhead and manufacturing efficiencies.

Operating Expenses

Selling, general and administrative expenses decreased $18,211 (3.3%) to $530,180 for the three months ended December 31, 2018 as compared to $548,391 for the three months ended December 31, 2017. This decrease is primarily attributed to lower salaries and related expenses, consulting and director fees offset partially by increased travel expenses.

Selling, general and administrative expenses decreased $228,956 (12.2%) to $1,652,116 for the nine months ended December 31, 2018 as compared to $1,881,072 for the nine months ended December 31, 2017, respectively. This decrease is primarily attributed to lower salaries and related expenses as well as lower commission and travel expenses partially offset by higher consulting and legal fees.

Litigation costs decreased $75,085 and $425,811 to $59,680 and $134,799 for the three and nine months ended December 31, 2018, respectively, as compared to $134,765 and $560,610 for the three and nine months ended December 31, 2017, respectively, as a result of less activity associated with the Aeroflex litigation. The Company has filed its appeal (see Notes 5 and 15 to Notes to the Condensed Consolidated Financial Statements).

For the nine months ended December 31, 2017, the Company recorded $2.1 million in additional legal damages as a result of the court’s decision regarding punitive damages last year (see Note 15 to Notes to the Condensed Consolidated Financial Statements).

Engineering, research and development expenses increased $75,391 (13.8%) to $622,082 for the three months ended December 31, 2018 as compared to $546,691 for the three months ended December 31, 2017. For the nine months ended December 31, 2018 engineering, research and development expenses decreased $48,846 (2.9%) to $1,642,785 as compared to $1,691,631 for the nine months ended December 31, 2018. The Company continues to invest in the development of the Company’s hand-held product line utilizing CRAFT and TS-4530A technology and the T47-M5 test set, the enhanced remote client, and the incorporation of other product enhancements in existing designs. The increased expenses for the quarter are associated with efforts to enhance the T-47M/5 for which the Company obtained AIMS PO approval, and accelerated efforts for our new hand-held product, the SDR-OMNI.

Income (Loss) from Operations

As a result of the above, the Company recorded income from operations of $757,662 for the three months ended December 31, 2018 as compared to a loss from operations of $293,167 for the three months ended December 31, 2017. For the nine months ended December 31, 2018, the Company recorded income from operations of $20,430 as compared to a loss from operations of $3,655,473 for the nine months ended December 31 2017.  

Other Income (Expense), Net

For the three months ended December 31, 2018, total other expense was $118,209, as compared to other expense of $40,269 for the three months ended December 31, 2017 as a result of accrued interest expense related to the judgment on the Aeroflex litigation and the loss on the change in fair value of the common stock warrants.

For the nine months ended December 31, 2018, total other expense was $318,460 as compared to other income of $115,357 for the nine months ended December 31, 2017 primarily as a result of accrued interest expense related to the judgment on the Aeroflex litigation. The nine months ended December 31, 2017 included a gain on the change in the valuation of common stock warrants as well as proceeds from a life insurance policy which did not occur in the during the first nine months of the current fiscal year ended December 31, 2018.

22

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).

Results of Operations (continued)

Income (Loss) before Income Taxes

As a result of the above, the Company recorded income before taxes of $639,453 for the three months ended December 31, 2018 as compared to a loss before taxes of $333,436 for the three months ended December 31, 2017.  For the nine months ended December 31, 2018 and 2017, the Company recorded losses before taxes of $298,030 and $3,540,116, respectively.  

Income Tax Benefit

For the three and nine months ended December 31, 2018 and December 31, 2017, the Company recorded no income tax benefit as such amounts were offset by a valuation allowance.

Net Income (Loss)

As a result of the above, the Company recorded net income of $639,453 for the three months ended December 31, 2018 as compared to a net loss of $333,436 for the three months ended December 31, 2017. For the nine months ended December 31, 2018 and 2017, the Company recorded net losses of $298,030 and $3,540,116, respectively.  

Liquidity and Capital Resources

At December 31, 2018, the Company had net negative working capital of $500,486 as compared to negative working capital of $1,335,879 at March 31, 2018. This change is primarily the result of the increase in accounts receivable and the decrease in accounts payable and accrued expenses offset partially by the decrease in inventories.

These consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern.  As reflected in the accompanying financial statements, for the year ended March 31, 2018, the Company incurred a net loss of $4,322,311, and also incurred a net loss of $298,030 for the nine months ended December 31, 2018. As discussed in Note 15 to the Notes to the Condensed Consolidated Financial Statements, the Company has recorded estimated damages to date of $5,216,647, including interest and additional fees, as a result of the jury verdict associated with the Aeroflex litigation. The Company’s line of credit agreement expired on Mach 31, 2018.  On August 29, 2018, the Company entered a Loan Modification Agreement (the “Agreement”) with the bank. The Company had been working with the bank and had paid $100,000 to lower the outstanding balance to $900,000 at the signing of the Agreement (see Note 9 to Notes to the Condensed Consolidated Financial Statements).

The Aeroflex litigation (see Note 15 to the Condensed Consolidated Financial Statements) did not result in a favorable outcome for the Company, despite our belief that we committed no wrong doing. The Judge did not change the result or vacate the damage award based on our latest motions, and, as such, we appealed this decision, and filed the appeal document (the “Appeal”) the week of May 28, 2018. The Company has established a $2 million cash bond and has filed an appeal on the $4.9 million in damages awarded by the court. The appeal brief is due to be filed in February 2019. We believe that the trial judge erred in his legal rulings on standing and other issues during the trial and that we have strong grounds for appeal. Our attorneys estimate that it will take several years for this appeal to work its way through the Kansas court system, but that ongoing future legal expenses will be nominal. We believe that we will have approximately two to three years to generate sufficient cash or secure additional financing to support the repayment of the remaining $2.9 million plus accrued interest not covered by the $2 million appeal bond, if we do not prevail with the appeal. However, the Company cannot predict the timing or the outcome of the appeal.

The Company believes it has sufficient financing in place to fund its plans for the next twelve months due in part to recent large orders it has received that should return the Company to profitability. The Company’s line of credit agreement expires on May 31, 2019.  On October 5, 2018, the Company entered into a definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock (the “Series B Preferred”) for $1 million. The Company used such proceeds for working capital purposes. We have no other firm commitments from any party to provide additional working capital and there is no assurance that any funding will be available as required, or if available, that its terms will be favorable or acceptable to the Company. The pending judgment raises substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.

The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

23

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).

Liquidity and Capital Resources (continued)

During the nine months ended December 31, 2018, the Company’s cash balance decreased by $146,781 to $161,031.  The Company’s principal sources and uses of funds were as follows:

Cash used in operating activities. For the nine months ended December 31, 2018, the Company used $1,090,867 in cash for operations as compared to using $3,399,429 in cash for operations for the nine months ended December 31, 2017.  This decrease in cash used for operations is attributed to the improvement in operating income and the decrease in inventories and not using $2,000,000 to obtain a letter of credit to secure the appeal bond which occurred in the prior fiscal year. This was partially offset by an increase in accounts receivable and a decrease in accounts payable and accrued expenses.

Cash used in investing activities.  For the nine months ended December 31, 2018, the Company used $-0- of its cash for investment activities, as compared to $89,396 for the nine months ended December 31, 2017 as a result of a decrease in the purchase of capital equipment.

Cash (used in) provided by financing activities. For the nine months ended December 31, 2018, the Company provided $944,086 in cash for financing activities as compared to providing $3,464,934 for the nine months ended December 31, 2017 primarily as a result of the no borrowings from the line of credit for the current fiscal year and due to the fact that the Company raised approximately $3 million from the issuance of preferred stock in the prior fiscal year as compared to approximately $1 million in the current fiscal year.

On March 21, 2016, the Company entered into a line of credit agreement with Bank of America, which expired March 31, 2017. In March 2017, the Company extended until March 31, 2018.  The line provided a revolving credit facility with borrowing capacity of up to $1,000,000. On August 29, 2018, the Company entered a Loan Modification Agreement (the “Agreement”) with the bank. The Company had been working with the bank and had paid $100,000 to the bank to lower the outstanding balance to $900,000 at the signing of the Agreement. The Agreement has the following provisions:

1) The Company to make an additional principal payment of $50,000 by October 1, 2018. (The Company made this payment.)

2) Borrowing base calculation tied to accounts receivable and inventories.

3) The Agreement expires May 31, 2019.

4) Interest on any outstanding balances is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points. The Company’s interest rate was 5.915% at December 31, 2018.

5) The line is collateralized by substantially all of the assets of the Company. 

6) The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019.

7) Beginning with the fiscal year ended March 31, 2019, the Company must maintain a debt service coverage ratio.

Currently, the Company has no material future capital expenditure requirements.

There was no significant impact on the Company’s operations as a result of inflation for the nine months ended December 31, 2018.

These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2018, filed with the SEC on July 16, 2018 (the “Annual Report”).

Off-Balance Sheet Arrangements

As of December 31, 2018, the Company had no off-balance sheet arrangements.

Critical Accounting Policies

Our critical accounting policies are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report. There have been no changes in our critical accounting policies. Our significant accounting policies are described in our notes to the 2018 consolidated financial statements included in our Annual Report.

24

Item 3.  Quantitative and Qualitative Disclosures about Market Risk.

We do not hold any derivative instruments and do not engage in any hedging activities.

Item 4.  Controls and Procedures.

(a)          Evaluation of Disclosure Controls and Procedures

The Company, including its principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based upon the evaluation, our principal executive officer and principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective. Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this report, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls include controls and procedures designed to reasonably ensure that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b)          Changes in Internal Control over Financial Reporting

The Company, including its principal executive officer and principal accounting officer, reviewed the Company’s internal control over financial reporting, pursuant to Rule 13(a)-15(e) under the Exchange Act and concluded that there was no change in the Company’s internal control over financial reporting during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

25

PART II – OTHER INFORMATION

Item 1.  Legal Proceedings.

The Aeroflex litigation (see Note 15 to the Condensed Consolidated Financial Statements) did not result in a favorable outcome for the Company, despite our belief that we committed no wrong doing. The Judge did not change the result or vacate the damage award based on our latest motions, and, as such, we appealed this decision, and filed the appeal document (the “Appeal”) the week of May 28, 2018. The Company has established a $2 million cash bond and has filed an appeal on the $4.9 million in damages awarded by the court. The appeal brief is due to be filed in February 2019. We believe that the trial judge erred in his legal rulings on standing and other issues during the trial and that we have strong grounds for appeal. Our attorneys estimate that it will take several years for this appeal to work its way through the Kansas court system, but that ongoing future legal expenses will be nominal. We believe that we will have approximately two to three years to generate sufficient cash or secure additional financing to support the repayment of the remaining $2.9 million plus accrued interest not covered by the $2 million appeal bond, if we do not prevail with the appeal. However, the Company cannot predict the timing or the outcome of the appeal.

Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

Item 1A.  Risk Factors.

We believe there are no changes that constitute material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2018, filed with the SEC on July 16, 2018.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.

There were no unregistered sales of the Company’s equity securities during the quarter ended December 31, 2018 other than those previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on October 9, 2018, regarding the issuance of Series B Preferred Stock.

Item 3.   Defaults upon Senior Securities.

There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company.

Item 4.   Mine Safety Disclosures.

Not applicable.  

Item 5.  Other Information.

There is no other information required to be disclosed under this item which was not previously disclosed.

26

Item 6.  Exhibits.

Exhibit No.	Description
10.1	Form of Subscription Agreement (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on October 9, 2018).
31.1	Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002*
31.2	Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002*
32.1	Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.INS	XBRL Instance Document*
101.SCH	Taxonomy Extension Schema Document*
101.CAL	Taxonomy Extension Calculation Linkbase Document*
101.DEF	Taxonomy Extension Definition Linkbase Document*
101.LAB	Taxonomy Extension Label Linkbase Document*
101.PRE	Taxonomy Extension Presentation Linkbase Document*

* Filed herewith

27

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TEL-INSTRUMENT ELECTRONICS CORP.
Date: February 8, 2019	By:	/s/ Jeffrey C. O’Hara
		Name: Jeffrey C. O’Hara
		Title:   Chief Executive Officer             Principal Executive Officer

Date: February 8, 2019	By:	/s/ Joseph P. Macaluso
		Name: Joseph P. Macaluso
		Title:   Principal Financial Officer             Principal Accounting Officer

28

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Jeffrey C. O’Hara, certify that:

1. I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. Along with the Principal Financial Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2019	By:	/s/ Jeffrey C. O’Hara
		Jeffrey C. O’Hara
		Principal Executive Officer Tel-Instrument Electronics Corp.

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Joseph P. Macaluso, certify that:

1. I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. Along with the Principal Executive Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2019	By:	/s/ Joseph P. Macaluso
		Joseph P. Macaluso
		Principal Financial Officer Tel-Instrument Electronics Corp.

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Tel-Instrument Electronics Corp. (the “Company”), on Form 10-Q for the quarter ended December 31, 2018, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Jeffrey C. O’Hara, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended December 31, 2018, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2018, fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 8, 2019	By:	/s/ Jeffrey C. O’Hara
		Jeffrey C. O’Hara
		Principal Executive Officer Tel-Instrument Electronics Corp.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Tel-Instrument Electronics Corp. (the “Company”), on Form 10-Q for the quarter ended December 31, 2018, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Joseph P. Macaluso, Principal Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended December 31, 2018 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2018 fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 8, 2019	By:	/s/ Joseph P. Macaluso
		Joseph P. Macaluso
		Principal Financial Officer Tel-Instrument Electronics Corp.

XML

Document And Entity Information - shares	9 Months Ended
	Dec. 31, 2018	Feb. 07, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	TEL INSTRUMENT ELECTRONICS CORP
Document Type	10-Q
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		3,255,887
Amendment Flag	false
Entity Central Index Key	0000096885
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2018	Mar. 31, 2018
Current assets:
Cash and cash equivalents	$ 161,031	$ 307,812
Accounts receivable, net	2,271,510	1,095,049
Inventories, net	3,094,276	4,269,934
Restricted cash to support appeal bond	2,003,883	2,000,866
Prepaid expenses and other current assets	240,390	147,746
Total current assets	7,771,090	7,821,407
Equipment and leasehold improvements, net	128,148	180,763
Deferred tax asset, net	63,500	63,500
Other long-term assets	35,109	35,109
Total assets	7,997,847	8,100,779
Current liabilities:
Current portion of long-term debt	0	2,124
Line of credit	820,000	1,000,000
Capital lease obligations – current portion	7,368	6,875
Accounts payable and accrued liabilities	1,796,782	2,580,383
Deferred revenues – current portion	92,204	60,051
Accrued legal damages	5,216,647	5,059,990
Warrant liability	23,000	0
Accrued payroll, vacation pay and payroll taxes	315,575	447,863
Total current liabilities	8,271,576	9,157,286
Capital lease obligations – long-term	1,295	6,885
Deferred revenues – long-term	274,170	337,676
Total liabilities	8,547,041	9,501,847
Commitments and contingencies
Stockholders’ deficit:
Preferred stock
Common stock, 7,000,000 shares authorized, par value $0.10 per share, 3,255,887 shares issued and outstanding, respectively	325,586	325,586
Paid-in capital in excess of par value, common stock	8,009,843	8,046,975
Accumulated deficit	(13,107,657)	(12,809,627)
Total stockholders’ deficit	(549,194)	(1,401,068)
Total liabilities and stockholders’ deficit	7,997,847	8,100,779
Series A Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock	3,215,998	3,035,998
Series B Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock	$ 1,007,036	$ 0

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares	9 Months Ended	12 Months Ended
	Dec. 31, 2018	Mar. 31, 2018
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)	$ 0.10	$ 0.10
Common stock, par value (in Dollars per share)	$ 0.10	$ 0.10
Common stock, shares issued	3,255,887	3,255,887
Common stock, shares outstanding	3,255,887	3,255,887
Common stock, shares authorized	7,000,000	7,000,000
Series A Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.10	$ 0.10
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	500,000	500,000
Preferred stock	8.00%	8.00%
Series B Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.10
Preferred stock, shares issued	166,667
Preferred stock, shares outstanding	166,667
Preferred stock	8.00%

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Net sales	$ 3,975,736	$ 2,625,793	$ 8,012,891	$ 7,955,035
Cost of sales	2,006,132	1,689,113	4,562,761	5,377,195
Gross margin	1,969,604	936,680	3,450,130	2,577,840
Operating expenses:
Selling, general and administrative	530,180	548,391	1,652,116	1,881,072
Litigation expenses	59,680	134,765	134,799	560,610
Legal damages	0	0	0	2,100,000
Engineering, research and development	622,082	546,691	1,642,785	1,691,631
Total operating expenses	1,211,942	1,229,847	3,429,700	6,233,313
Income (loss) from operations	757,662	(293,167)	20,430	(3,655,473)
Other income (expense):
Interest income	1,010	0	3,017	0
Proceeds from life insurance	0	0	0	92,678
Amortization of deferred financing costs	0	(649)	0	(3,363)
Change in fair value of common stock warrants	(23,000)	5,000	(23,000)	95,000
Interest expense - judgment	(72,003)	(30,523)	(215,226)	(30,523)
Interest expense	(24,216)	(14,097)	(83,251)	(38,435)
Total other (expense) income	(118,209)	(40,269)	(318,460)	115,357
Income (loss) before income taxes	639,453	(333,436)	(298,030)	(3,540,116)
Income tax expense	0	0	0	0
Net income (loss)	639,453	(333,436)	(298,030)	(3,540,116)
Deemed dividend related to beneficial conversion feature of Series B Convertible Preferred Stock	(420,000)	0	(420,000)	0
Preferred stock dividends	(112,807)	(30,667)	(232,807)	(30,667)
Net income (loss) attributable to common shareholders	$ 106,646	$ (364,103)	$ (950,837)	$ (3,570,783)
Basic income (loss) per common share (in Dollars per share)	$ 0.03	$ (0.11)	$ (0.29)	$ (1.10)
Diluted income (loss) per common share (in Dollars per share)	$ 0.03	$ (0.11)	$ (0.29)	$ (1.10)
Weighted average shares outstanding:
Basic (in Shares)	3,255,887	3,255,887	3,255,887	3,255,887
Diluted (in Shares)	3,409,657	3,255,887	3,255,887	3,255,887

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (298,030)	$ (3,540,116)
Adjustments to reconcile net loss to net cash used in operating activities:
Deferred income taxes	0	0
Depreciation and amortization	52,615	53,221
Provision for inventory obsolescence	55,000	50,000
Amortization of deferred financing costs	0	3,363
Change in fair value of common stock warrant	23,000	(95,000)
Non-cash stock-based compensation	18,597	23,180
Changes in assets and liabilities:
Increase in accounts receivable	(1,176,461)	(104,375)
Decrease (increase) in inventories	1,120,658	(151,145)
(Increase) decrease in prepaid expenses & other assets	(92,644)	76,165
Restricted cash for appeal bond	(3,017)	(2,000,000)
(Decrease) increase in accounts payable and other accrued expenses	(783,601)	358,808
Decrease in federal and state taxes	0	(4,105)
Decrease in accrued payroll, vacation pay & withholdings	(132,288)	(131,206)
Decrease in deferred revenues	(31,353)	(68,742)
Increase in accrued legal damages	156,657	2,130,523
Net cash used in operating activities	(1,090,867)	(3,399,429)
Cash flows from investing activities:
Purchases of equipment	0	(89,396)
Net cash used in investing activities	0	(89,396)
Cash flows from financing activities:
Proceeds from line of credit	0	800,000
Repayment of line of credit	(180,000)	0
Proceeds from issuance of preferred stock, net of expenses	987,925	2,960,000
Repayment of long-term debt	(2,124)	(290,419)
Proceeds from short-swing profits from an investor, net of expenses	143,382	0
Repayment of capitalized lease obligations	(5,097)	(4,646)
Net cash provided by financing activities	944,086	3,464,935
Net decrease in cash and cash equivalents	(146,781)	(23,890)
Cash and cash equivalents at beginning of period	307,812	287,873
Cash and cash equivalents at end of period	161,031	263,983
Supplemental cash flow information:
Taxes paid	0	5,000
Interest paid	$ 41,475	$ 50,374

XML

Note 1 - Basis of Presentation

9 Months Ended

Dec. 31, 2018

Disclosure Text Block [Abstract]

Basis of Accounting [Text Block]

Note 1 – Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. (the “Company” or “TIC” or “Tel”) as of December 31, 2018, the results of operations for the three and nine months ended December 31, 2018 and December 31, 2017, and statements of cash flows for the nine months ended December 31, 2018 and December 31, 2017.  These results are not necessarily indicative of the results to be expected for the full year.  The financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K.  The March 31, 2018 balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date.  Accordingly, the financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2018, as filed with the United States Securities and Exchange Commission (the “SEC”) on July 16, 2018 (the “Annual Report”).

XML

Note 2 - Liquidity and Going Concern

9 Months Ended

Dec. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Substantial Doubt about Going Concern [Text Block]

Note 2 – Liquidity and Going Concern

These consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern.  As reflected in the accompanying financial statements, for the year ended March 31, 2018, the Company incurred a net loss of $4,322,311 and a loss of $298,030 for the nine months ended December 31, 2018. As discussed in Note 15 to the Notes to the Condensed Consolidated Financial Statements, the Company has recorded estimated damages to date of $5,216,647, including interest and additional fees, as a result of the jury verdict associated with the Aeroflex litigation. The Company has filed for an appeal.

The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company’s post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim.  The Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. The Court heard these motions and such motions were denied. The Company has filed for the appeal. The Company has posted a $2,000,000 bond for the appeal. This $2 million bond amount will remain in place during the appeal process (See Note 15). The Company believes it has solid grounds to appeal this verdict. The appeal process is expected to take several years to complete. However, the Company cannot predict the timing or the outcome of the appeal.

The Company believes it has sufficient financing in place to fund its plans for the next twelve months due in part to recent large orders it has received that should return the Company to profitability. The Company’s line of credit agreement expires on May 31, 2019.  On October 5, 2018, the Company entered into a definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock (the “Series B Preferred”) for $1 million. The Company intends to use such proceeds for working capital purposes. We have no other firm commitments from any party to provide additional working capital and there is no assurance that any funding will be available as required, or if available, that its terms will be favorable or acceptable to the Company. The pending judgment raises substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.

The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

Note 3 - Summary of Significant Accounting Policies

9 Months Ended

Dec. 31, 2018

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

Note 3 – Summary of Significant Accounting Policies

During the nine months ended December 31, 2018, there have been no material changes in the Company’s significant accounting policies to those previously disclosed in the Annual Report.

XML

Note 4 - Accounts Receivable, net

9 Months Ended

Dec. 31, 2018

Receivables [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

Note 4 – Accounts Receivable, net

The following table sets forth the components of accounts receivable:

	December 31, 2018			March 31, 2018
Government	$	2,208,470		$	998,522
Commercial		70,540			104,027
Less: Allowance for doubtful accounts		(7,500	)		(7,500	)
	$	2,271,510		$	1,095,049

XML

Note 5 - Restricted Cash to support appeal bond

9 Months Ended

Dec. 31, 2018

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents Disclosure [Text Block]

Note 5 – Restricted Cash to support appeal bond

The Company transferred $2,000,000 to a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Notes 13 and 15).

XML

Note 6 - Inventories, net

9 Months Ended

Dec. 31, 2018

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

Note 6 – Inventories, net

Inventories consist of:

	December 31, 2018			March 31, 2018
Purchased parts	$	2,799,562		$	3,571,874
Work-in-process		769,714			1,051,725
Finished goods		-			66,335
Less: Inventory reserve		(475,000	)		(420,000	)
	$	3,094,276		$	4,269,934

XML

Note 7 - Net Income (Loss) per Share

9 Months Ended

Dec. 31, 2018

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Note 7 – Net Income (Loss) per Share

Net income (loss) per share has been computed according to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 260”), “Earnings per Share,” which requires a dual presentation of basic and diluted income (loss) per share (“EPS”). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including preferred stock, warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation costs attributed to future services. 

	Three Months Ended			Three Months Ended
	December 31, 2018			December 31, 2017
Basic net income (loss) per share computation:
Net income (loss)	$	639,453		$	(333,436	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(112,807	)		(30,667	)
Net income (loss) attributable to common shareholders		106,646			(364,103	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net income (loss) per share	$	0.03		$	(0.11	)
Diluted net income (loss) per share computation
Net income (loss)	$	639,453		$	(333,436	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(112,807	)		(30,667	)
Diluted income (loss) attributable to common shareholders	$	106,646			(364,103	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed exercise of       preferred stock, outstanding stock options and warrants		153,770			-
Total adjusted weighted-average shares		3,409,657			3,255,887
Diluted net income (loss) per share	$	0.03		$	(0.11	)

	Nine Months Ended			Nine Months Ended
	December 31, 2018			December 31, 2017
Basic net loss per share computation:
Net loss	$	(298,030	)	$	(3,540,116	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(232,807	)		(30,667	)
Net loss attributable to common shareholders		(950,837	)		(3,570,783	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net income per share	$	(0.29	)	$	(1.10	)
Diluted net loss per share computation
Net loss	$	(298,030	)	$	(3,540,116	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)
Add: Preferred dividends		(232,807	)		(30,667	)
Diluted loss attributable to common shareholders	$	(950,837	)		(3,570,783	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants		-			-
Total adjusted weighted-average shares		3,255,887			3,255,887
Diluted net loss per share	$	(0.29	)	$	(1.10	)

The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share:

	December 31, 2018		December 31, 2017
Convertible preferred stock (see Notes 13 and 14 for amounts to      be paid for conversion which the Company would receive)		1,599,778		1,000,000
Stock options		42,500		75,000
Warrants		50,000		50,000
		1,692,278		1,125,000

XML

Note 8 - Long-Term Debt

9 Months Ended

Dec. 31, 2018

Disclosure Text Block [Abstract]

Long-term Debt [Text Block]

Note 8 – Long-Term Debt

Term Loans with Bank of America

In July 2015, the Company entered into a term loan in the amount of $18,000 with Bank of America. The term loan was for three years, and matured in July 2018. Monthly payments were $536 including interest at 4.5%. The term loan was collateralized by substantially all of the assets of the Company. At December 31, 2018 and March 31, 2018, the outstanding balances were $-0- and $2,124, respectively. This loan was paid in full in July 2018.

XML

Note 9 - Line of Credit

9 Months Ended

Dec. 31, 2018

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

Note 9 – Line of Credit

On March 21, 2016, the Company entered into a line of credit agreement with Bank of America, which expired March 31, 2017. In March 2017, the Company extended until March 31, 2018.  The line provided a revolving credit facility with borrowing capacity of up to $1,000,000. There were no covenants or borrowing base calculations associated with this line of credit. On August 29, 2018, the Company entered a Loan Modification Agreement (the “Agreement”) with the bank. The Company had been working with the bank and had paid $100,000 to the bank to lower the outstanding balance to $900,000 at the signing of the Agreement. The Agreement has the following provisions:

1) The Company to make an additional principal payment of $50,000 by October 1, 2018. (The Company made this payment.)

2) Borrowing base calculation tied to accounts receivable and inventories.

3) The Agreement expires May 31, 2019.

4) Interest on any outstanding balances is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points. The Company’s interest rate was 5.915% at September 30, 2018.

5) The line is collateralized by substantially all of the assets of the Company. 

6) The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019.

7) Beginning with the fiscal year ended March 31, 2019, the Company must maintain a debt service coverage ratio.

During the nine months ended December 31, 2018, the Company repaid $180,000 against this line of credit. As of December 31, 2018 and March 31, 2018, the outstanding balances were $820,000 and $1,000,000, respectively.  As of December 31, 2018 the remaining availability under this line is $-0-.

XML

Note 10 - Segment Information

9 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 10 – Segment Information

In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial. There are no inter-segment revenues.

The Company is organized primarily on the basis of its avionics products.  The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors.  The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops. The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments.

Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis.  Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level. The table below presents information about reportable segments within the avionics business for the three and nine month periods ending December 31, 2018 and 2017:

Three Months Ended  December 31, 2018	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	3,484,380	$	491,356	$	3,975,736	$	-		$	3,975,736
Cost of sales		1,735,573		270,559		2,006,132		-			2,006,132
Gross margin		1,748,807		220,797		1,969,604		-			1,969,604
Engineering, research, and development						622,082		-			622,082
Selling, general and administrative						228,107		302,073			530,180
Litigation costs								59,680			59,680
Change in fair value of common stock warrants								23,000			23,000
Interest income						-		(1,010	)		(1,010	)
Interest expense - judgment								72,003			72,003
Interest expense						-		24,216			24,216
Total expenses						850,189		479,962			1,330,151
Income (loss) before income taxes					$	1,119,415	$	(479,962	)	$	639,453

Three Months Ended  December 31, 2017	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	1,825,744	$	800,049	$	2,625,793	$	-		$	2,625,793
Cost of sales		1,013,481		675,632		1,689,113		-			1,689,113
Gross margin		812,263		124,417		936,680		-			936,680
Engineering, research, and development						546,691		-			546,691
Selling, general and administrative						225,610		322,781			548,391
Litigation costs								134,765			134,765
Legal damages								30,523			30,523
Amortization of deferred financing costs						-		649			649
Change in fair value of common stock warrants						-		(5,000	)		(5,000	)
Proceeds from life insurance								-			-
Interest expense						-		14,097			14,097
Total expenses						772,301		497,815			1,270,116
Income (loss) before income taxes					$	164,379	$	(497,815	)	$	(333,436	)

Nine Months Ended  December 31, 2018	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	5,861,061	$	2,151,830	$	8,012,891	$	-		$	8,012,891
Cost of sales		3,211,417		1,351,344		4,562,761		-			4,562,761
Gross margin		2,649,644		800,486		3,450,130		-			3,450,130
Engineering, research, and development						1,642,785		-			1,642,785
Selling, general and administrative						639,414		1,012,702			1,652,116
Litigation costs								134,799			134,799
Change in fair value of common stock warrants						-		23,000			23,000
Interest income								(3,017	)		(3,017	)
Interest expense - judgment								215,226			215,226
Interest expense						-		83,251			83,251
Total expenses						2,282,199		1,465,961			3,748,160
Income (loss) before income taxes					$	1,167,931	$	(1,465,961	)	$	(298,030	)

Nine Months Ended  December 31, 2017	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	5,826,763	$	2,128,272	$	7,955,035	$	-		$	7,955,035
Cost of sales		3,489,223		1,887,972		5,377,195		-			5,377,195
Gross margin		2,337,540		240,300		2,577,840		-			2,577,840
Engineering, research, and development						1,691,631		-			1,691,631
Selling, general and administrative						861,795		1,019,277			1,881,072
Litigation costs								560,610			560,610
Legal damages								2,130,523			2,130,523
Amortization of deferred financing costs						-		3,363			3,363
Change in fair value of common stock warrants						-		(95,000	)		(95,000	)
Proceeds from life insurance								(92,678	)		(92,678	)
Interest expense, net						-		38,435			38,435
Total expenses						2,553,426		3,564,530			6,117,956
Income (loss) before income taxes					$	24,414	$	(3,564,530	)	$	(3,540,116	)

XML

Note 11 - Income Taxes

9 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

Note 11 – Income Taxes

FASB ASC 740-10, “Accounting for Uncertainty in Income Taxes” (“ASC 740-10”) prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions.  The Company does not have any unrecognized tax benefits.

The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset.  Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse.  The Company has approximately $3.5 million in deferred tax assets, and we have provided a valuation allowance that offsets the majority of the asset. The inability to obtain new profitable contracts or the failure of the Company’s engineering development efforts could reduce estimates of future profitability, which could affect the Company’s ability to realize the deferred tax assets. Due to the adverse judgment and the resulting losses the past few years, management has established a valuation allowance against this deferred tax asset. This valuation allowance could be reversed when the Company returns to profitability, and can demonstrate that it will be able to utilize the deferred tax asset.

XML

Note 12 - Fair Value Measurements

9 Months Ended

Dec. 31, 2018

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

Note 12 – Fair Value Measurements

FASB ASC 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”) defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and expands disclosures about fair value measurements.

As defined in ASC 820-10, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price).  The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique.  These inputs can be readily observable, market corroborated, or generally unobservable.  The Company classifies fair value balances based on the observation of those inputs. ASC 820-10 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy defined by ASC 820-10 are as follows:

-  Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.  Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

-  Level 2 – Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date.  Level 2 includes those financial instruments that are valued using models or other valuation methodologies.  These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.  Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.  Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

-  Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources.  These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

 The valuation techniques that may be used to measure fair value are as follows:

● Market approach — Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

● Income approach — Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method.

● Cost approach — Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost). 

The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility reflect currently available terms and conditions for similar debt.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of December 31, 2018 and March 31, 2018.  As required by ASC 820-10, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.

December 31, 2018	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		23,000		23,000
Total Liabilities	$	-	$	-	$	23,000	$	23,000

March 31, 2018	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		-		-
Total Liabilities	$	-	$	-	$	-	$	-

The Company adopted the guidance of ASC 815 “Derivative and Hedging”, which requires that we mark the value of our warrant liability to market and recognize the change in valuation in our statement of operations each reporting period. Determining the warrant liability to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  

The following table provides a summary of the changes in fair value of our Level 3 financial liabilities from March 31, 2018 through December 31, 2018, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to the liability held at December 31, 2018:

Level 3 Reconciliation	Balance at beginning of period		(Gains) and losses for the period (realized and unrealized)		Purchases, issuances, sales and settlements, net		Transfers in or out of Level 3		Balance at the end of period
Warrant liability	$	-	$	23,000	$	-	$	-	$	23,000
Total Liabilities	$	-	$	23,000	$	-	$	-	$	23,000

The Company has remaining warrants with an outside investor to purchase 50,000 shares of the Company’s common stock at an exercise price of $3.35 per share or exercising the “put option” to the Company.  The warrant liability of the 50,000 warrants was $23,000 at December 31, 2018 as compared to $-0- at March 31, 2018.

XML

Note 13 - Series A 8% Convertible Preferred Stock

9 Months Ended

Dec. 31, 2018

Disclosure Text Block Supplement [Abstract]

Preferred Stock [Text Block]

Note 13 – Series A 8% Convertible Preferred Stock

On November 14, 2017, the Company entered into definitive subscription agreements with an accredited investor, pursuant to which the investor purchased an aggregate of 500,000 shares of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred”) for an aggregate of $3 million. The Company used $2,000,000 of the proceeds to be placed in a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Notes 5 and 15) and the remaining amount was used for working capital purposes, and for payment of fees and expenses associated with this transaction. The Closing occurred following the satisfaction of customary closing conditions. The securities issued pursuant to the Subscription Agreements were not registered under the Securities Act of 1933, as amended (the “Securities Act”), but qualified for exemption under Section 4(a)(2) of the Securities Act. The securities were exempt from registration under Section 4(a)(2) of the Securities Act because the issuance of such securities by the Company did not involve a “public offering,” as defined in Section 4(a)(2) of the Securities Act, due to the insubstantial number of persons involved in the transaction, size of the offering, manner of the offering and number of securities offered. The Company did not undertake an offering in which it sold a high number of securities to a high number of investors. In addition, these shareholders had the necessary investment intent as required by Section 4(a)(2) of the Securities Act since they agreed to, and received, share certificates bearing a legend stating that such securities are restricted pursuant to Rule 144 of the Securities Act. This restriction ensures that these securities would not be immediately redistributed into the market and therefore not be part of a “public offering.” Based on an analysis of the above factors, the Company has met the requirements to qualify for exemption under Section 4(a)(2) of the Securities Act.

The shares of Series A Preferred have a stated value of $6.00 per share (the “Series A Stated Value”) and are convertible into Common Stock at a price of $3.00 per share. The holders of shares of the Series A Preferred shall be entitled to receive dividends out of any assets legally available, to the extent permitted by New Jersey law, at an annual rate equal to 8% of the Series A Stated Value of such shares of Series A Preferred, calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series A Preferred, payable quarterly in cash. Any unpaid dividends shall accrue at the same rate. To the extent not paid on the last day of March, June, September and December of each calendar year, all dividends on any share of Series A Preferred shall accumulate whether or not declared by the Board and shall remain accumulated dividends until paid. As of December 31, 2018, the Company has accrued $330,667 for dividends.

The Holders will vote together with the holders of the Company’s Common Stock on an as-converted basis on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). Effective beginning on the third anniversary of the Original Issue Date, and upon 30 days’ written notice to the Holders of Series A Preferred, the Company may, in its sole discretion, redeem the Series A Preferred at the aggregate Series A Stated Value plus any accrued and accumulated but unpaid dividends.

The Company has also evaluated its convertible preferred stock in accordance with the provisions of ASC 815, Derivatives and Hedging, including consideration of embedded derivatives requiring bifurcation. The issuance of the convertible preferred stock could generate a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Series A Convertible Preferred Stock, and the associated dividends, did not generate a BCF upon issuance as the fair value of the Company's common stock was greater than the conversion price. During the quarter December 31, 2018 the Company measured a BCF based on the fair value of our stock price on the date dividends were declared. The BCF amounted to $16,200 on the associated dividend.

XML

Note 14 - Series B 8% Convertible Preferred Stock

9 Months Ended

Dec. 31, 2018

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Note 14 – Series B 8% Convertible Preferred Stock

On October 5, 2018, the Company entered into definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock (the “Series B Preferred”) for an aggregate of $1 million. The Company used such proceeds for working capital to finance its operations based on the current and expected increase in business, and for payment of fees and expenses associated with this transaction. The Closing occurred following the satisfaction of customary closing conditions. The securities issued pursuant to this subscription agreement were not registered under the Securities Act of 1933, as amended (the “Securities Act”), but qualified for exemption under Section 4(a)(2) of the Securities Act. The securities were exempt from registration under Section 4(a)(2) of the Securities Act because the issuance of such securities by the Company did not involve a “public offering,” as defined in Section 4(a)(2) of the Securities Act, due to the insubstantial number of persons involved in the transaction, size of the offering, manner of the offering and number of securities offered. The Company did not undertake an offering in which it sold a high number of securities to a high number of investors. In addition, this individual had the necessary investment intent as required by Section 4(a)(2) of the Securities Act since he agreed to, receive share certificates bearing a legend stating that such securities are restricted pursuant to Rule 144 of the Securities Act. This restriction ensures that these securities would not be immediately redistributed into the market and therefore not be part of a “public offering.” Based on an analysis of the above factors, the Company has met the requirements to qualify for exemption under Section 4(a)(2) of the Securities Act.

The shares of Series B Preferred have a stated value of $6.00 per share (the “Series B Stated Value”) and are convertible into Common Stock at a price of $2.00 per share. The holder of shares of the Series B Preferred shall be entitled to receive dividends out of any assets legally available, to the extent permitted by New Jersey law, at an annual rate equal to 8% of the Series B Stated Value of such shares of Series B Preferred, calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series B Preferred, payable quarterly in cash. Any unpaid dividends shall accrue at the same rate. To the extent not paid on the last day of March, June, September and December of each calendar year, all dividends on any share of Series B Preferred shall accumulate whether or not declared by the Board and shall remain accumulated dividends until paid. As of December 31, 2018, the Company accrued $19,111 for dividends.

The Holders will vote together with the holders of the Company’s Common Stock on an as-converted basis on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). Effective beginning on the third anniversary of the Original Issue Date, and upon 30 days’ written notice to the Holders of Series B Preferred, the Company may, in its sole discretion, redeem the Series B Preferred at the aggregate Series B Stated Value plus any accrued and accumulated but unpaid dividends.

The Company has also evaluated its convertible preferred stock in accordance with the provisions of ASC 815, Derivatives and Hedging, including consideration of embedded derivatives requiring bifurcation. The issuance of the convertible preferred stock could generate a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Company recognized the BCF by allocating the intrinsic value of the conversion option, which is the number of shares of common stock available upon conversion multiplied by the difference between the effective conversion price per share and the fair value of common stock per share on the commitment date, to additional paid-in capital, resulting in a discount on the convertible preferred stock. As the convertible preferred stock may be converted immediately, the Company recognized a BCF of $420,000 as a deemed dividend in the condensed statements of operations for the three and nine months ended December 31, 2018. The deemed dividend had no impact on the Company’s stockholders’ deficit. The associated dividend for the Series B preferred stock generated a BCF in the amount of $17,496 for the period ended December 31, 2018.

XML

Note 15 - Litigation

9 Months Ended

Dec. 31, 2018

Disclosure Text Block Supplement [Abstract]

Legal Matters and Contingencies [Text Block]

Note 15 – Litigation

Contingencies are recorded in the consolidated financial statements when it is probable that a liability will be incurred and the amount of the loss is reasonably estimable, or otherwise disclosed, in accordance with Accounting Standards Codification 450, Contingencies (ASC 450). Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In the event the Company determines that a loss is not probable, but is reasonably possible, and it becomes possible to develop what the Company believes to be a reasonable range of possible loss, then the Company will include disclosures related to such matter as appropriate and in compliance with ASC 450. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company will, when applicable, adjust the accrual in the period the determination is made, disclose an estimate of the additional loss or range of loss or if the amount of such adjustment cannot be reasonably estimated, disclose that an estimate cannot be made.

On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the “Award”). Aeroflex’s petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with Aeroflex’s business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex’s contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award.  In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”).

In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed on Aeroflex’s proprietary technology in winning the Award, and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.

In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings.

On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex’s lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire. Aeroflex’s claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2011. The motion for summary judgment was denied.

The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a nine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company.

Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex’s tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.  Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.

During July 2017, the Court heard the Company’s motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million.

Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In October 2017, the Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages, which brings the total Tel damages awarded in this case to approximately $4.9 million.

The Company filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. A hearing on this motion was held. The Judge rejected all of our arguments and declined to order a new trial. We filed the appeal document the week of May 28. The Company has posted a $2,000,000 bond. This $2 million bond amount will remain in place during the appeal process (See Note 5).

On July 5, 2018, Plaintiff Aeroflex Wichita, Inc. filed a Notice of Cross-Appeal which is contingent in nature in that it seeks a review of all adverse rulings relating to its Motion for Relief and Sanctions; Defendants’ Motions for Summary Judgment; determining that certain matters were not trade secrets; Defendants’ joint and several liability; preemption under the Kansas Uniform Trade Secrets Act; motions in limine; motions for judgment as a matter of law; jury instructions; admission of evidence over its objections; and all other rulings adverse to it only if the court reverses the jury verdict and judgment. Aeroflex Wichita also reserved the right to ask the reviewing court to order a new trial either on damages alone or on liability for all claims. This reservation of rights is also contingent upon a finding of the appellate court which would reverse the jury verdict and judgment. Aeroflex Wichita filed its Docketing Statement on July 5, 2018 as well .

On July 11, 2018, the Court of Appeals entered an Order of Referral to Mediation and Order to Stay. The Company’s case was selected to participate in the Kansas Court of Appeals Appellate Mediation pilot program. Participation in the program is voluntary, either party may opt out of participation. The order staying the case was lifted because Aeroflex Wichita, Inc. opted out, and as a result the appeal will proceed under normal procedures.

The Company is continuing with its appeal against this adverse decision. The appeal brief is due to be filed in February 2019. We believe that the trial judge erred in his legal rulings on standing and other issues during the trial and that we have strong grounds for appeal. Our attorneys estimate that it will take several years for this appeal to work its way through the Kansas court system, but that ongoing future legal expenses will be nominal. We believe that we will have approximately two to three years to generate sufficient cash or secure additional financing to support the repayment of the remaining $2.9 million plus accrued interest not covered by the $2 million appeal bond, if we do not prevail with the appeal.

Other than the matters described above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

XML

Note 16 - New Accounting Pronouncements

9 Months Ended

Dec. 31, 2018

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

Note 16 – New Accounting Pronouncements

Recently Adopted Authoritative Pronouncements

Revenue Recognition

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers: Topic 606 which supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of Topic 606 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The ASU defines a five-step process to achieve the core principal and, in doing so, it is possible more judgement and estimates may be required within the revenue recognition process than are currently in use. The ASU was effective for the Company in the first quarter of 2019 using either of two methods: (1) retrospective application to each prior reporting period presented with the option to elect certain practical expedients or (2) retrospective application with the cumulative effect of initially applying the ASU recognized at the date of the initial application and providing certain disclosures. We adopted Topic 606 pursuant to the method (2) and we determined that any cumulative effect for the initial application did not require an adjustment to retained earnings at April 1, 2018.

The Company generates revenue from designing, manufacturing and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment. 

Under Financial Accounting Standards Board (“FASB”) Topic 606, Revenue from Contacts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

Nature of goods and services

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each.

Test Units/Sets

The Company develops, and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for radios installed in aircraft. The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract. Revenue on products are presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement, and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to the customer.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines     stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component as of December 31, 2018.

Replacement Parts

The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test units, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled.

Extended Warranties

The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms generally ranging from 5 to 7 years. Amounts received for warranties are recorded as deferred revenue and recognized as revenue ratably over the respective term of the agreements. As of December 31, 2018, approximately $366,374 is expected to be recognized from remaining performance obligations for extended warranties.  For the nine months ended December 31, 2018, the Company recognized revenue of $33,255 from amounts that were included in Deferred Revenue.

Repair and Calibration Services

The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped, as it is at this time that the work is completed.

The majority of the Company’s revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, and other commercial customers. The contracts with the U.S. government typically are subject to the Federal Acquisition Regulation (“FAR”) which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts.

Payment terms and conditions vary by contract, although terms generally include a requirement of payment within a range from 30 to 60 days, or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts generally do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. Shipping and handling costs charged to customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales. 

Disaggregation of revenue

In the following tables, revenue is disaggregated by revenue category.

	For the Three Months Ended December 31, 2018
	Commercial		Government
Sales Distribution
Test Units	$	46,631	$	3,484,380
Repairs and Calibration		366,563		-
Replacement Parts		64,527		-
Extended Warranty		13,635		-
	$	491,356	$	3,484,380

	For the Nine Months Ended December 31, 2018
	Commercial		Government
Sales Distribution
Test Units	$	642,855	$	5,861,061
Repairs and Calibration		1,285,839		-
Replacement Parts		189,881		-
Extended Warranty		33,255		-
	$	2,151,830	$	5,861,061

In the following table, revenue is disaggregated by geography.

	For the Three Months Ended December 31, 2018		For the Nine Months Ended December 31, 2018
Geography
United States	$	3,088,693	$	6,363,404
International		887,043		1,649,487
Total	$	3,975,736	$	8,012,891

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which requires lessees to put most leases on their balance sheets by recognizing a lessee’s rights and obligations, while expenses will continue to be recognized in a similar manner to today’s legacy lease accounting guidance. This ASU could also significantly affect the financial ratios used for external reporting and other purposes, such as debt covenant compliance. This ASU will be effective for the Company on April 1, 2019, with early adoption permitted. The Company is currently in the process of assessing the impact of this ASU on our consolidated financial statements.

No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s consolidated financial statements.

XML

Note 17 - Reclassifications

9 Months Ended

Dec. 31, 2018

Disclosure Text Block [Abstract]

Reclassifications [Text Block]

Note 17 – Reclassifications

Certain prior year and period amounts have been reclassified to conform to the current period presentation.

XML

Note 4 - Accounts Receivable, net (Tables)

9 Months Ended

Dec. 31, 2018

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

The following table sets forth the components of accounts receivable:

	December 31, 2018			March 31, 2018
Government	$	2,208,470		$	998,522
Commercial		70,540			104,027
Less: Allowance for doubtful accounts		(7,500	)		(7,500	)
	$	2,271,510		$	1,095,049

XML

Note 6 - Inventories, net (Tables)

9 Months Ended

Dec. 31, 2018

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

Inventories consist of:

	December 31, 2018			March 31, 2018
Purchased parts	$	2,799,562		$	3,571,874
Work-in-process		769,714			1,051,725
Finished goods		-			66,335
Less: Inventory reserve		(475,000	)		(420,000	)
	$	3,094,276		$	4,269,934

XML

Note 7 - Net Income (Loss) per Share (Tables)

9 Months Ended

Dec. 31, 2018

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended			Three Months Ended
	December 31, 2018			December 31, 2017
Basic net income (loss) per share computation:
Net income (loss)	$	639,453		$	(333,436	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(112,807	)		(30,667	)
Net income (loss) attributable to common shareholders		106,646			(364,103	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net income (loss) per share	$	0.03		$	(0.11	)
Diluted net income (loss) per share computation
Net income (loss)	$	639,453		$	(333,436	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(112,807	)		(30,667	)
Diluted income (loss) attributable to common shareholders	$	106,646			(364,103	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed exercise of       preferred stock, outstanding stock options and warrants		153,770			-
Total adjusted weighted-average shares		3,409,657			3,255,887
Diluted net income (loss) per share	$	0.03		$	(0.11	)

	Nine Months Ended			Nine Months Ended
	December 31, 2018			December 31, 2017
Basic net loss per share computation:
Net loss	$	(298,030	)	$	(3,540,116	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)		-
Add: Preferred dividends		(232,807	)		(30,667	)
Net loss attributable to common shareholders		(950,837	)		(3,570,783	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net income per share	$	(0.29	)	$	(1.10	)
Diluted net loss per share computation
Net loss	$	(298,030	)	$	(3,540,116	)
Add: Deemed dividend related to beneficial conversion feature               of Series B Convertible Preferred Stock		(420,000	)
Add: Preferred dividends		(232,807	)		(30,667	)
Diluted loss attributable to common shareholders	$	(950,837	)		(3,570,783	)
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants		-			-
Total adjusted weighted-average shares		3,255,887			3,255,887
Diluted net loss per share	$	(0.29	)	$	(1.10	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share:

	December 31, 2018		December 31, 2017
Convertible preferred stock (see Notes 13 and 14 for amounts to      be paid for conversion which the Company would receive)		1,599,778		1,000,000
Stock options		42,500		75,000
Warrants		50,000		50,000
		1,692,278		1,125,000

XML

Note 10 - Segment Information (Tables)

9 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis. Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level. The table below presents information about reportable segments within the avionics business for the three and nine month periods ending December 31, 2018 and 2017:

Three Months Ended  December 31, 2018	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	3,484,380	$	491,356	$	3,975,736	$	-		$	3,975,736
Cost of sales		1,735,573		270,559		2,006,132		-			2,006,132
Gross margin		1,748,807		220,797		1,969,604		-			1,969,604
Engineering, research, and development						622,082		-			622,082
Selling, general and administrative						228,107		302,073			530,180
Litigation costs								59,680			59,680
Change in fair value of common stock warrants								23,000			23,000
Interest income						-		(1,010	)		(1,010	)
Interest expense - judgment								72,003			72,003
Interest expense						-		24,216			24,216
Total expenses						850,189		479,962			1,330,151
Income (loss) before income taxes					$	1,119,415	$	(479,962	)	$	639,453

Three Months Ended  December 31, 2017	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	1,825,744	$	800,049	$	2,625,793	$	-		$	2,625,793
Cost of sales		1,013,481		675,632		1,689,113		-			1,689,113
Gross margin		812,263		124,417		936,680		-			936,680
Engineering, research, and development						546,691		-			546,691
Selling, general and administrative						225,610		322,781			548,391
Litigation costs								134,765			134,765
Legal damages								30,523			30,523
Amortization of deferred financing costs						-		649			649
Change in fair value of common stock warrants						-		(5,000	)		(5,000	)
Proceeds from life insurance								-			-
Interest expense						-		14,097			14,097
Total expenses						772,301		497,815			1,270,116
Income (loss) before income taxes					$	164,379	$	(497,815	)	$	(333,436	)

Nine Months Ended  December 31, 2018	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	5,861,061	$	2,151,830	$	8,012,891	$	-		$	8,012,891
Cost of sales		3,211,417		1,351,344		4,562,761		-			4,562,761
Gross margin		2,649,644		800,486		3,450,130		-			3,450,130
Engineering, research, and development						1,642,785		-			1,642,785
Selling, general and administrative						639,414		1,012,702			1,652,116
Litigation costs								134,799			134,799
Change in fair value of common stock warrants						-		23,000			23,000
Interest income								(3,017	)		(3,017	)
Interest expense - judgment								215,226			215,226
Interest expense						-		83,251			83,251
Total expenses						2,282,199		1,465,961			3,748,160
Income (loss) before income taxes					$	1,167,931	$	(1,465,961	)	$	(298,030	)

Nine Months Ended  December 31, 2017	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	5,826,763	$	2,128,272	$	7,955,035	$	-		$	7,955,035
Cost of sales		3,489,223		1,887,972		5,377,195		-			5,377,195
Gross margin		2,337,540		240,300		2,577,840		-			2,577,840
Engineering, research, and development						1,691,631		-			1,691,631
Selling, general and administrative						861,795		1,019,277			1,881,072
Litigation costs								560,610			560,610
Legal damages								2,130,523			2,130,523
Amortization of deferred financing costs						-		3,363			3,363
Change in fair value of common stock warrants						-		(95,000	)		(95,000	)
Proceeds from life insurance								(92,678	)		(92,678	)
Interest expense, net						-		38,435			38,435
Total expenses						2,553,426		3,564,530			6,117,956
Income (loss) before income taxes					$	24,414	$	(3,564,530	)	$	(3,540,116	)

XML

Note 12 - Fair Value Measurements (Tables)

9 Months Ended

Dec. 31, 2018

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.

December 31, 2018	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		23,000		23,000
Total Liabilities	$	-	$	-	$	23,000	$	23,000

March 31, 2018	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		-		-
Total Liabilities	$	-	$	-	$	-	$	-

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table provides a summary of the changes in fair value of our Level 3 financial liabilities from March 31, 2018 through December 31, 2018, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to the liability held at December 31, 2018:

Level 3 Reconciliation	Balance at beginning of period		(Gains) and losses for the period (realized and unrealized)		Purchases, issuances, sales and settlements, net		Transfers in or out of Level 3		Balance at the end of period
Warrant liability	$	-	$	23,000	$	-	$	-	$	23,000
Total Liabilities	$	-	$	23,000	$	-	$	-	$	23,000

XML

Note 16 - New Accounting Pronouncements (Tables)

9 Months Ended

Dec. 31, 2018

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]

In the following tables, revenue is disaggregated by revenue category.

	For the Three Months Ended December 31, 2018
	Commercial		Government
Sales Distribution
Test Units	$	46,631	$	3,484,380
Repairs and Calibration		366,563		-
Replacement Parts		64,527		-
Extended Warranty		13,635		-
	$	491,356	$	3,484,380

	For the Nine Months Ended December 31, 2018
	Commercial		Government
Sales Distribution
Test Units	$	642,855	$	5,861,061
Repairs and Calibration		1,285,839		-
Replacement Parts		189,881		-
Extended Warranty		33,255		-
	$	2,151,830	$	5,861,061

Revenue from External Customers by Geographic Areas [Table Text Block]

In the following table, revenue is disaggregated by geography.

	For the Three Months Ended December 31, 2018		For the Nine Months Ended December 31, 2018
Geography
United States	$	3,088,693	$	6,363,404
International		887,043		1,649,487
Total	$	3,975,736	$	8,012,891

XML

Note 2 - Liquidity and Going Concern (Details) - USD ($)		1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 05, 2018	Oct. 31, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Mar. 31, 2018
Note 2 - Liquidity and Going Concern (Details) [Line Items]
Net Income (Loss) Attributable to Parent				$ 639,453	$ (333,436)	$ (298,030)	$ (3,540,116)	$ (4,322,311)
Estimated Litigation Liability				5,216,647		5,216,647
Restricted Cash, Current				2,003,883		2,003,883		$ 2,000,866
Stock Issued During Period, Shares, New Issues (in Shares)	166,667
Proceeds from Issuance or Sale of Equity	$ 1,000,000
Aeroflex [Member]
Note 2 - Liquidity and Going Concern (Details) [Line Items]
Loss Contingency, Damages Awarded, Value		$ 2,100,000	$ 2,800,000
Restricted Cash, Current				$ 2,000,000		$ 2,000,000
Aeroflex [Member]
Note 2 - Liquidity and Going Concern (Details) [Line Items]
Loss Contingency, Damages Awarded, Value		$ 2,100,000	$ 2,800,000

XML

Note 4 - Accounts Receivable, net (Details) - Schedule of Accounts, Notes, Loans and Financing Receivable - USD ($)	Dec. 31, 2018	Mar. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less: Allowance for doubtful accounts	$ (7,500)	$ (7,500)
Accounts Receivable, net	2,271,510	1,095,049
Government Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable	2,208,470	998,522
Commercial Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable	$ 70,540	$ 104,027

XML

Note 5 - Restricted Cash to support appeal bond (Details)	Dec. 31, 2018 USD ($)
Aeroflex [Member]
Note 5 - Restricted Cash to support appeal bond (Details) [Line Items]
Restricted Cash, Current	$ 2,000,000

XML

Note 6 - Inventories, net (Details) - Schedule of Inventory, Current - USD ($)	Dec. 31, 2018	Mar. 31, 2018
Schedule of Inventory, Current [Abstract]
Purchased parts	$ 2,799,562	$ 3,571,874
Work-in-process	769,714	1,051,725
Finished goods	0	66,335
Less: Inventory reserve	(475,000)	(420,000)
	$ 3,094,276	$ 4,269,934

XML

Note 7 - Net Income (Loss) per Share (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Mar. 31, 2018
Basic net income (loss) per share computation:
Net loss income	$ 639,453	$ (333,436)	$ (298,030)	$ (3,540,116)	$ (4,322,311)
Add: Deemed dividend related to beneficial conversion feature of Series B Convertible Preferred Stock	(420,000)	0	(420,000)	0
Add: Preferred dividends	(112,807)	(30,667)	(232,807)	(30,667)
Diluted loss income	106,646	(364,103)	(950,837)	(3,570,783)
Net income (loss) attributable to common shareholders	$ 106,646	$ (364,103)	$ (950,837)	$ (3,570,783)
Weighted-average common shares outstanding (in Shares)	3,255,887	3,255,887	3,255,887	3,255,887
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants (in Shares)	153,770	0	0	0
Total adjusted weighted-average shares (in Shares)	3,409,657	3,255,887	3,255,887	3,255,887
Diluted net loss per share (in Dollars per share)	$ 0.03	$ (0.11)	$ (0.29)	$ (1.10)
Basic net loss per share (in Dollars per share)	$ 0.03	$ (0.11)	$ (0.29)	$ (1.10)

XML

Note 7 - Net Income (Loss) per Share (Details) - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share - shares	9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Securities	1,692,278	1,125,000
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Securities	1,599,778	1,000,000
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Securities	42,500	75,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Securities	50,000	50,000

XML

Note 8 - Long-Term Debt (Details) - Notes Payable to Banks [Member] - Note to Bank #1 [Member] - USD ($)	1 Months Ended
	Jul. 31, 2015	Dec. 31, 2018	Mar. 31, 2018
Note 8 - Long-Term Debt (Details) [Line Items]
	$ 18,000
Debt Instrument, Term	3 years
Debt Instrument, Maturity Date, Description	July 2018
Debt Instrument, Frequency of Periodic Payment	Monthly
Debt Instrument, Periodic Payment	$ 536
Debt Instrument, Interest Rate, Stated Percentage	4.50%
Debt Instrument, Collateral	collateralized by substantially all of the assets of the Company
Notes Payable		$ 0	$ 2,124

XML

Note 9 - Line of Credit (Details) - Line of Credit [Member] - USD ($)		1 Months Ended	9 Months Ended
	Aug. 29, 2018	Mar. 31, 2017	Dec. 31, 2018	Mar. 31, 2018
Note 9 - Line of Credit (Details) [Line Items]
Line of Credit Facility, Expiration Date	May 31, 2019	Mar. 31, 2018
Line of Credit Facility, Maximum Borrowing Capacity		$ 1,000,000
Repayments of Long-term Lines of Credit	$ 100,000
Long-term Line of Credit	900,000		$ 820,000	$ 1,000,000
Line of Credit Facility, Periodic Payment	$ 50,000
Line of Credit Facility, Interest Rate at Period End			5.915%
Debt Instrument, Payment Terms	The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019.
Repayments of Lines of Credit			$ 180,000
Line of Credit Facility, Remaining Borrowing Capacity			$ 0
London Interbank Offered Rate (LIBOR) [Member]
Note 9 - Line of Credit (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	3.75%

XML

Note 10 - Segment Information (Details)	9 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Number of Reportable Segments	2

XML

Note 10 - Segment Information (Details) - Schedule of Segment Reporting Information, by Segment - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Net sales	$ 3,975,736	$ 2,625,793	$ 8,012,891	$ 7,955,035
Cost of sales	2,006,132	1,689,113	4,562,761	5,377,195
Gross margin	1,969,604	936,680	3,450,130	2,577,840
Engineering, research, and development	622,082	546,691	1,642,785	1,691,631
Selling, general and administrative	530,180	548,391	1,652,116	1,881,072
Litigation costs	59,680	134,765	134,799	560,610
Legal damages		30,523		2,130,523
Amortization of deferred financing costs	0	649	0	3,363
Change in fair value of common stock warrants	23,000	(5,000)	23,000	(95,000)
Proceeds from life insurance	0	0	0	(92,678)
Interest income	(1,010)	0	(3,017)	0
Interest expense - judgment	72,003	30,523	215,226	30,523
Interest expense, net	24,216	14,097	83,251	38,435
Total expenses	1,330,151	1,270,116	3,748,160	6,117,956
Income (loss) before income taxes	639,453	(333,436)	(298,030)	(3,540,116)
Avionics Government [Member]
Segment Reporting Information [Line Items]
Net sales	3,484,380	1,825,744	5,861,061	5,826,763
Cost of sales	1,735,573	1,013,481	3,211,417	3,489,223
Gross margin	1,748,807	812,263	2,649,644	2,337,540
Avionics Commercial [Member]
Segment Reporting Information [Line Items]
Net sales	491,356	800,049	2,151,830	2,128,272
Cost of sales	270,559	675,632	1,351,344	1,887,972
Gross margin	220,797	124,417	800,486	240,300
Avionics Total [Member]
Segment Reporting Information [Line Items]
Net sales	3,975,736	2,625,793	8,012,891	7,955,035
Cost of sales	2,006,132	1,689,113	4,562,761	5,377,195
Gross margin	1,969,604	936,680	3,450,130	2,577,840
Engineering, research, and development	622,082	546,691	1,642,785	1,691,631
Selling, general and administrative	228,107	225,610	639,414	861,795
Amortization of deferred financing costs		0		0
Change in fair value of common stock warrants		0	0	0
Interest income	0		0
Interest expense, net	0	0	0	0
Total expenses	850,189	772,301	2,282,199	2,553,426
Income (loss) before income taxes	1,119,415	164,379	1,167,931	24,414
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Net sales	0	0	0	0
Cost of sales	0	0	0	0
Gross margin	0	0	0	0
Engineering, research, and development	0	0	0	0
Selling, general and administrative	302,073	322,781	1,012,702	1,019,277
Litigation costs	59,680	134,765	134,799	560,610
Legal damages		30,523		2,130,523
Amortization of deferred financing costs		649		3,363
Change in fair value of common stock warrants	23,000	(5,000)	23,000	(95,000)
Proceeds from life insurance		0		(92,678)
Interest income	(1,010)		(3,017)
Interest expense - judgment	72,003		215,226
Interest expense, net	24,216	14,097	83,251	38,435
Total expenses	479,962	497,815	1,465,961	3,564,530
Income (loss) before income taxes	$ (479,962)	$ (497,815)	$ (1,465,961)	$ (3,564,530)

XML

Note 11 - Income Taxes (Details) $ in Millions	Dec. 31, 2018 USD ($)
Income Tax Disclosure [Abstract]
Deferred Tax Assets, Valuation Allowance	$ 3.5

XML

Note 12 - Fair Value Measurements (Details) - Warrants Held by Outside Investor [Member] - USD ($)	Dec. 31, 2018	Mar. 31, 2018
Note 12 - Fair Value Measurements (Details) [Line Items]
Warrants and Rights Outstanding	$ 50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 3.35
Derivative Liability, Noncurrent	$ 23,000	$ 0

XML

Note 12 - Fair Value Measurements (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis - USD ($)	Dec. 31, 2018	Mar. 31, 2018
Note 12 - Fair Value Measurements (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total Assets	$ 0	$ 0
Warrant liability	23,000	0
Total Liabilities	23,000	0
Fair Value, Inputs, Level 1 [Member]
Note 12 - Fair Value Measurements (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total Assets	0	0
Warrant liability	0	0
Total Liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Note 12 - Fair Value Measurements (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total Assets	0	0
Warrant liability	0	0
Total Liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
Note 12 - Fair Value Measurements (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total Assets	0	0
Warrant liability	23,000	0
Total Liabilities	$ 23,000	$ 0

XML

Note 12 - Fair Value Measurements (Details) - Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [	12 Months Ended
	Mar. 31, 2018 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	$ 0
(Gains) and losses for the period (realized and unrealized)	23,000
Purchases, issuances, sales and settlements, net	0
Transfers in or out of Level 3	0
Balance	23,000
Warrant [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	0
(Gains) and losses for the period (realized and unrealized)	23,000
Purchases, issuances, sales and settlements, net	0
Transfers in or out of Level 3	0
Balance	$ 23,000

XML

Note 13 - Series A 8% Convertible Preferred Stock (Details) - USD ($)			9 Months Ended	12 Months Ended
	Oct. 05, 2018	Nov. 14, 2017	Dec. 31, 2018	Mar. 31, 2018
Note 13 - Series A 8% Convertible Preferred Stock (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	166,667
Restricted Cash		$ 2,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)			$ 0.10	$ 0.10
Series A Preferred Stock [Member]
Note 13 - Series A 8% Convertible Preferred Stock (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)		500,000
Proceeds from Issuance of Convertible Preferred Stock		$ 3,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)		$ 6.00	$ 0.10	$ 0.10
Convertible Preferred Stock, Conversion Price (in Dollars per share)		$ 3.00
Preferred Stock, Dividend Rate, Percentage		8.00%	8.00%	8.00%
Preferred Stock, Conversion Basis		calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series A Preferred, payable quarterly in cash
Dividends Payable, Current			$ 330,667
Debt Instrument, Convertible, Beneficial Conversion Feature			$ 16,200

XML

Note 14 - Series B 8% Convertible Preferred Stock (Details) - Series B Preferred Stock [Member] - USD ($)		9 Months Ended
	Oct. 05, 2018	Dec. 31, 2018
Note 14 - Series B 8% Convertible Preferred Stock (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	166,667
Proceeds from Issuance of Convertible Preferred Stock	$ 1,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$ 6.00	$ 0.10
Convertible Preferred Stock, Conversion Price (in Dollars per share)	$ 2.00
Preferred Stock, Dividend Rate, Percentage	8.00%	8.00%
Preferred Stock, Conversion Basis	calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series B Preferred, payable quarterly in cash
Dividends Payable, Current	$ 19,111
Preferred Stock Dividends and Other Adjustments		$ 420,000
Debt Instrument, Convertible, Beneficial Conversion Feature		$ 17,496

XML

Note 15 - Litigation (Details) - Aeroflex [Member] - USD ($)	1 Months Ended			9 Months Ended
	Jan. 31, 2018	Oct. 31, 2017	Mar. 31, 2017	Dec. 31, 2018
Note 15 - Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value		$ 2,100,000	$ 2,800,000
Loss Contingency, Estimate of Possible Loss		$ 4,900,000
Loss Contingency, Damages Sought	The Company filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. A hearing on this motion was held. The Judge rejected all of our arguments and declined to order a new trial. We filed the appeal document the week of May 28. The Company has posted a $2,000,000 bond. This $2 million bond amount will remain in place during the appeal process (See Note 5).
Restricted Cash	$ 2,000,000
Loss Contingency Accrual, Provision				$ 2,900,000
Business Opportunity [Member]
Note 15 - Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value			1,300,000
Non-Disclosure Agreements [Member]
Note 15 - Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value			525,000
Loss Contingency, Damages Sought, Value			1,500,000
Maximum [Member]
Note 15 - Litigation (Details) [Line Items]
Loss Contingency, Damages Sought, Value			$ 5,000,000

XML

Note 16 - New Accounting Pronouncements (Details)	9 Months Ended
	Dec. 31, 2018 USD ($)
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Extended Product Warranty Description	terms generally ranging from 5 to 7 years
Extended Product Warranty Accrual	$ 366,374
Recognition of Deferred Revenue	$ 33,255

XML

Note 16 - New Accounting Pronouncements (Details) - Schedule of Changes in Accounting Principals - USD ($)	3 Months Ended	9 Months Ended
	Dec. 31, 2018	Dec. 31, 2018
Commercial [Member]
Sales Distribution
Sales by revenue category	$ 491,356	$ 2,151,830
Government Sales [Member]
Sales Distribution
Sales by revenue category	3,484,380	5,861,061
Test Units [Member] | Commercial [Member]
Sales Distribution
Sales by revenue category	46,631	642,855
Test Units [Member] | Government Sales [Member]
Sales Distribution
Sales by revenue category	3,484,380	5,861,061
Repairs and Calibration [Member] | Commercial [Member]
Sales Distribution
Sales by revenue category	366,563	1,285,839
Repairs and Calibration [Member] | Government Sales [Member]
Sales Distribution
Sales by revenue category	0	0
Replacement Parts [Member] | Commercial [Member]
Sales Distribution
Sales by revenue category	64,527	189,881
Replacement Parts [Member] | Government Sales [Member]
Sales Distribution
Sales by revenue category	0	0
Extended Warranty [Member] | Commercial [Member]
Sales Distribution
Sales by revenue category	13,635	33,255
Extended Warranty [Member] | Government Sales [Member]
Sales Distribution
Sales by revenue category	$ 0	$ 0

XML

Note 16 - New Accounting Pronouncements (Details) - Revenue from External Customers by Geographic Areas - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Geography
Revenues	$ 3,975,736	$ 2,625,793	$ 8,012,891	$ 7,955,035
UNITED STATES
Geography
Revenues	3,088,693		6,363,404
International [Member]
Geography
Revenues	$ 887,043		$ 1,649,487